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ABSTRACT 
 
Bone tissue engineering has emerged as a promising alternative in cases of injured and 
diseased bone, which may not be capable of self-repairing. In such clinical 
circumstances, an appropriate biomaterial should be applied to the defective site to 
substitute lost bone and to initiate bone regeneration. The regeneration of bone tissue 
requires a suitable microenvironment that closely mimics the host site for desired 
cellular responses, which is typically provided by three-dimensional (3D) scaffolds that 
acts as an architectural template. A 3D scaffold for bone tissue engineering needs to 
fulfill stringent requirements, such as biocompatibility, appropriate mechanical 
support, controlled degradation consistent with sufficient structural integrity, 
containing a porous structure with interconnected pores, and osteoconductive 
properties. It should also have adequate physicochemical behavior to direct cell-
material and cell-cell interactions. Furthermore, the possibility of promoting bone 
tissue growth while simultaneously preventing biofilm formation, and consequently 
implant-related infections, by developing antimicrobial surfaces as integral component 
of 3D hydrogels would be particularly advantageous for orthopedic surgery 
applications. Recent advances have greatly expanded the processing windows for silk 
fibroin (SF) porous hydrogels. SF is a natural, biocompatible, and biodegradable 
polymer having a great potential for the successful regeneration of damaged bone 
tissue. This polymer can be combined with a bioactive ceramic producing a new 
material for bone implants. In this context, nanophased hydroxyapatite (nanoHA) has 
received considerable attention due to its excellent bioactive and osteoconductive 
properties as it bonds to bone and enhances bone tissue formation, increasing the 
osteogenic potential of the material. The purpose of the present work was to develop 
and characterize a novel composite hydrogel of SF and nanoHA for bone regeneration. 
SF based hydrogels incorporating different percentages of nanoHA, by using a new and 
innovative method, were developed. These hydrogels of SF with nanoHA were 
subsequently frozen or non-frozen to evaluate the effect of this on the material 
properties. The physicochemical properties of the composite material incorporating 
nanoHA were studied. Biological investigations with human bone marrow stromal cells 
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(hBMSCs) and antimicrobial studies against orthopedic pathogens related to implanted 
medical devices were conducted. Results showed an interconnected porous structure 
combined with micro- and macroporosity, and the frozen hydrogels presented higher 
pore sizes when compared to the non-frozen materials. The hydrogel with 15 wt% 
nanoHA, obtained by the freezing method, yielded a composite with improved 
mechanical properties together with a higher amount of uniformly dispersed nanoHA 
particles throughout the SF matrix, making the composite hydrogel suitable for bone 
regeneration. Additionally, preliminary biological data performed with osteoblast-like 
cells MG63 showed promising results regarding osteoblastic cell response on frozen 
SF/nanoHA materials. Subsequently, biological investigations of hBMSCs viability, 
proliferation and differentiation to the osteoblastic phenotype were carried-out to 
exploit the suitability of the SF/15 wt% nanoHA hydrogel for bone regenerative 
strategies. The biological results highlighted that the SF/nanoHA hydrogels can act as a 
matrix for hBMSCs attachment and proliferation, which was significantly improved on 
frozen composite materials. Furthermore, a test for alkaline phosphatase (ALP) and 
bone morphogenetic protein 2 (BMP-2) expression suggested improved osteoblast 
differentiation for frozen SF/nanoHA hydrogels. In addition, an ALP live stain method 
allowed the observation of cell infiltration, and consequently migration, with active 
production of ALP by the infiltrated cells, which can ensure bone in-growth and bone 
tissue regeneration. Equally important, the rapid emergence of resistant bacterial 
strains to antibiotics prompted us to develop new materials exhibiting antimicrobial 
properties. SF/nanoHA hydrogels were modified with in situ synthetized silver and gold 
nanoparticles (AgNPs and AuNPs) and the antimicrobial activity toward orthopedic 
pathogens associated to implant infections was evaluated. It was found that the 
bacterial inhibition of hydrogels with AuNPs was not so high when compared to 
materials with AgNPs. Furthermore, the hydrogels containing 0.5% of AgNPs presented 
strong antibacterial activity, reducing the bacterial attachment and further 
accumulation, while simultaneously allowing for the adhesion and spreading of 
osteoblastic cells. These results suggested that these antimicrobial hydrogels may be 
used to prevent material colonization and, subsequent implant-related infections, 
without compromising bone tissue regeneration.  
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RESUMO 
 
A engenharia de tecidos surge como uma alternativa promissora em casos de lesões 
ósseas em que não há a possibilidade de auto-regeneração. Nestas circunstâncias, a 
aplicação de um biomaterial apropriado no defeito ósseo é fundamental para iniciar e 
permitir a regeneração óssea. Para tal, a utilização de uma matriz tridimensional (3D) 
pode proporcionar o microambiente necessário para obter a resposta celular 
pretendida. A matriz 3D necessita de possuir determinadas propriedades de forma a 
preencher os requisitos para este tipo de abordagem regenerativa. O material deve ser 
biocompatível, com suficiente suporte mecânico, uma degradação controlada 
consistente com integridade estrutural, possuir uma estrutura porosa com poros 
interconectados, e propriedades osteocondutoras. Um comportamento físico-químico 
adequado de forma a direcionar as interações célula-material e célula-célula também é 
fundamental. Além disso, a possibilidade de ter um material que além de promover o 
crescimento do tecido ósseo também previna a formação de biofilme, e 
consequentemente as infeções relacionadas com implantes, é uma mais valia para 
aplicações cirúrgicas ortopédicas. O desenvolvimento de hidrogéis porosos de fibroína 
da seda (SF) é uma área em grande expansão. A SF é um polímero natural, 
biocompatível e biodegradável com grande potencial em estratégias de regeneração 
do tecido ósseo. A combinação deste polímero com um cerâmico bioativo conduz à 
produção de um novo material para ser aplicado em implantes ósseos. Neste contexto, 
a nanohidroxiapatite (nanoHA) atrai enorme atenção devido à sua excelente 
bioatividade e osteocondutividade, uma vez que se liga ao osso e conduz à formação 
de novo tecido ósseo, aumentando assim o potencial osteogénico do material. Desta 
forma, o objetivo deste trabalho foi desenvolver e caraterizar um novo hidrogel 
composto por SF e nanoHA para a regeneração óssea. Para tal, diferentes 
percentagens de nanoHA foram incorporadas nos hidrogéis de SF através de um novo 
método, e alguns dos materiais foram submetidos a congelamento para avaliar 
diferenças nas propriedades dos materiais congelados e não congelados. As 
propriedades físico-químicas dos materiais obtidos com nanoHA foram estudadas. Os 
hidrogéis foram também utilizados para a realização de estudos biológicos com células 
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do estroma da medula óssea (hBMSCs) e estudos antimicrobianos com 
microrganismos patogénicos associados a dispositivos médicos. Os resultados 
mostraram um material com estrutura porosa, com poros interconectados, e com 
micro e macro porosidade. Além disso, os hidrogéis submetidos a congelamento 
apresentaram tamanho de poros maior quando comparados com os materiais não 
congelados. O hidrogel com 15% de nanoHA, obtido pelo método de congelamento, 
apresentou melhores propriedades mecânicas juntamente com uma maior quantidade 
de partículas de nanoHA uniformemente dispersas na matriz de SF, tornando este 
material adequado para a regeneração óssea. Dados biológicos preliminares, obtidos 
através da utilização de células osteoblásticas MG63, mostraram resultados 
promissores relativamente à resposta das células osteoblásticas nos hidrogéis de SF 
com nanoHA. Consequentemente, realizaram-se estudos biológicos de viabilidade, 
proliferação, e diferenciação osteoblástica com hBMSCs, para explorar o potencial do 
hidrogel de SF com 15% de nanoHA para a regeneração óssea. Estes resultados 
mostraram que os hidrogéis de SF com nanoHA podem atuar como uma matriz para a 
adesão e proliferação das hBMSCs, um comportamento que foi significativamente 
melhor nos materiais compósitos submetidos a congelamento. Além disso, através da 
avaliação da expressão da fosfatase alcalina (ALP) e da proteína morfogenética óssea 
tipo 2 (BMP-2) observou-se uma diferenciação osteoblástica mais evidente nos 
hidrogéis de SF com nanoHA congelados. Adicionalmente, um método de coloração 
para a ALP em células vivas permitiu observar infiltração celular, e consequentemente 
migração celular, com produção ativa de ALP pelas células infiltradas, o que pode 
assim assegurar o crescimento ósseo e por conseguinte a regeneração do tecido ósseo. 
Igualmente importante de destacar é o rápido surgimento de estirpes bacterianas 
resistentes a antibióticos, sendo necessário o desenvolvimento de novos materiais 
com propriedades antimicrobianas. Neste seguimento, os hidrogéis de SF com nanoHA 
foram modicados com nanopartículas de prata e ouro (AgNPs e AuNPs), sintetizadas in 
situ no material compósito, e a atividade antimicrobiana destes hidrogéis foi avaliada 
com espécies relevantes envolvidas em infeções de implantes ósseos. Os resultados 
mostraram que a inibição bacteriana dos hidrogéis com AuNPs não foi tão elevada 
quando comparada com os materiais com AgNPs. Além disso, os hidrogéis com 0.5% 
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de AgNPs apresentaram robusta atividade antimicrobiana, reduzindo a adesão 
bacteriana e subsequente acumulação, e em simultâneo permitiram a adesão das 
células osteoblásticas. Assim, estes resultados sugerem que estes hidrogéis 
antimicrobianos podem ser utilizados para prevenir a colonização do material e, 
subsequente infeção, sem comprometer a regeneração do tecido ósseo.  
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AIMS OF THE THESIS  
 
There is a high demand by the orthopedic medical community for implant materials 
that are capable to promote bone tissue growth while preventing bacterial adhesion 
and, consequently, implant-associated infections. Hence, the aim of this thesis was to 
develop silk fibroin (SF) porous hydrogels mineralized with nanohydroxyapatite 
(nanoHA) for bone regeneration. SF is a natural, biocompatible, and biodegradable 
polymer having a great potential for the regeneration of damaged bone tissue. In the 
context of creating more effective bioactive hydrogels, this polymer can be combined 
with a nanoHA ceramic producing a new composite material for bone implants. 
NanoHA is one of the most widely used calcium phosphate ceramics due to its 
chemical similarities to the inorganic component of natural bone tissue. Additionally, 
the excellent bioactive and osteoconductive properties of nanoHA can increase the 
osteogenic potential of the material, as it bonds to bone and enhances bone tissue 
formation. Therefore, the present work was focused on the preparation and 
characterization of new SF/nanoHA porous hydrogels mimicking the physiologic 
environment present during bone tissue formation. In this context, hydrogels were 
assayed for bone cell functions and bacterial adhesion. The specific aims proposed in 
this work are listed below: 
 
- Preparation of SF/nanoHA porous hydrogels by impregnation of nanosized particles 
of hydroxyapatite into fibroin solution, and subsequent physicochemical 
characterization. 
 
- In vitro biological performance of SF/nanoHA hydrogels using human bone marrow 
stromal cells, cultured up to 21 days, and evaluated for cell adhesion, morphology, 
viability, proliferation, and differentiation events. 
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- Assessment of the antimicrobial effect of SF/nanoHA hydrogels modified with in 
situ synthetized silver and gold nanoparticles against major agents of biomaterial-
associated infections in orthopedics. 
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1. Motivation behind bone tissue engineering 
 
Tissue engineering is a multidisciplinary field focused on the development of biological 
substitutes to repair or regenerate tissue functionality with the aim of helping to 
restore the functions during regeneration and subsequent integration with the host 
tissue [1, 2]. The fundamental concept behind tissue engineering it to utilize the body’s 
natural biological response to tissue damage in conjunction with engineering 
principles. In this regard, significant attention is being given to three-dimensional 
scaffolds with specific physical, mechanical and biological properties. An ideal scaffold 
for bone tissue engineering is a matrix that acts as a temporary substrate for cell 
growth, proliferation and support for new tissue formation, and simultaneously is 
degraded to provide location for the newly formed tissue [1-3].   
Bone is a dynamic and highly vascularized tissue that forms the main elements of the 
skeleton and continues to remodel throughout the lifetime of an individual. Bones not 
only provide the mechanical support for locomotion, but also offers protection to 
vulnerable internal organs. In addition to these structural functions it is considered as 
the main reservoir of mineral ions such as calcium, phosphate and other inorganic ions 
intimately involved in homeostasis by regulating the concentration of key electrolytes 
in the blood [3, 4]. The importance of bone becomes even clearer in the case of 
diseases such as osteogenesis imperfecta, osteoarthritis, osteomyelitis, and 
osteoporosis where bone does not perform adequately. These diseases along with 
traumatic injury, orthopaedic surgeries (i.e., total joint arthroplasty, spine arthrodesis, 
implant fixation) and primary tumour resection lead to or induce bone defects or voids 
[3]. Bone is nowadays one of the most transplanted tissues, with an incidence of nearly 
15 million fracture cases per year [5]. Traditionally, the treatment of bone defects has 
relied on autografts, where bone tissue is transplanted from one site to another in the 
same patient, but the donor site morbidity and pain, limited supply especially in elderly 
and fragile population, constrained by anatomical limitations are significant problems 
[6-8]. As an alternative option, allografts, bone tissue transplanted from one individual 
to another, offer the advantage of allowing the surgeon to place a graft of the same 
anatomic location, and consequently with very similar mechanical and biochemical 
properties. However, they also have drawbacks, mainly associated with the risk of 
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donor to recipient infection, disease transmission and adverse host immune response 
along with possible graft rejection [6-9]. Considering these severe drawbacks of the 
current treatment methods, as well as constantly increasing incidence of bone defects 
as a consequence of the aging population, there is clearly a huge demand on the 
development of novel and more sophisticated synthetic biomaterials, for which the 
bone tissue engineering has a potential to answer.  
With respect to the biomaterial, a functional scaffold for bone tissue engineering 
should meet stringent requirements, such as biocompatibility with host tissues without 
eliciting any immune response, appropriate mechanical support to withstand the 
mechanical loading in vivo, contain a porous architecture with interconnected pores to 
encourage cell ingrowth and vascularization, and osteoinductive properties to recruit 
and differentiate osteoprogenitors to the defect region. It must also possess 
appropriate chemical and topographical properties to positively influence cellular 
adhesion, proliferation and differentiation, and a controlled degradation consistent 
with sufficient structural integrity until the newly grown tissue has replaced the 
scaffold’s are properties that should also be addressed. In filling up bone defects, 
considerations such as the manufacturability and easy clinical handling are also 
essential [3, 10, 11].  
In order to gain insight into choosing the type of materials that can best mimic the 
physicochemical properties of bone, a clear concept of the bone biology, physiology, 
and anatomy of bone is essential.  
 
1.1. Bone properties 
 
Bone is a sophisticated composite organized into hierarchical architecture over several 
length scales, from macroscopic to nanoscale dimensions, where the basic building 
blocks are the plate-like HAp nanocrystals incorporated into collagen fibers, as shown 
in Figure 1. Bone is a natural composite material consisting primarily of a type I 
collagen-containing organic phase as a matrix and a an inorganic phase composed of 
natural apatite, a non-stoichiometric, partially substituted and partially crystalline 
variety of hydroxyapatite (Ca10(PO4)6(OH)2). Bone matrix is built up of type I collagen 
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amounting to about 90% of total bone protein and the remaining organic component 
is composed of a large number non-collagenous proteins like osteocalcin, osteonectin, 
osteopontin, bone sialoprotein and several proteoglycans. The hardness of bone is 
attributed to the deposition of complex mineral substances, calcium hydroxyapatite 
composed of calcium, phosphorus, sodium, magnesium, fluoride and other ions in 
trace amounts, within the soft organic matrix of collagen, which is responsible for the 
toughness, flexibility and visco-elasticity [4, 12-14]. 
 
Figure 1 - Bone is a complex, hierarchically structured biological material that 
comprises macro, micro and nano components. Bone has a strong calcified outer 
compact layer (a), which comprises many cylindrical Haversian systems, or osteons (b). 
The resident cells are coated in a forest of cell membrane receptors that respond to 
specific binding sites (c) and the well-defined nanoarchitecture of the surrounding 
extracellular matrix (d) [4].  
 
Two different mature bone structures can be identified in different parts of the bone: 
cortical (compact) and trabecular (cancellous) bone. Trabecular bone constitutes 20% 
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of the total adult bone tissue and is a spongy structure with 50-90% porosity, filled 
with bone marrow. Cortical bone is a compact structural tissue, comprising 80% of 
adult bone tissue, with only 10% porosity [10, 15, 16]. The cortical bone contains 
osteons (Harversian systems), which are composed of a central canal (Haversian canal) 
surrounded by lamellae of bone matrix, and within the lamellae there are osteocytes 
embedded in tiny spaces (lacunae). The Harversian canal encompasses blood vessels 
and nerve cells throughout the bone and communicates with osteocytes in lacunae 
through canaliculi, The periosteum consists of an outer fibrous layer and an inner one 
that has osteogenic potential and enables the bone to enlarge [14, 17].   
Bone contains different cell types, namely osteoblasts (bone matrix producing cells), 
osteocytes (mature osteoblasts that are embedded in the mineralized matrix), 
osteoclasts (bone matrix degrading cells) and osteoprogenitors (immature cells 
capable of differentiating into osteoblasts - found in the bone marrow and periosteum) 
[15]. Undifferentiated mesenchymal stem cells (MSCs) give rise to osteoprogenitor 
cells which in turn form osteoblasts. Osteoprogenitor cells are also located in 
periosteum, endosteum, and Haversian canals and placed on standby, ready for a 
stimulus signal to start proliferating and differentiating into osteoblasts before forming 
bone. Osteoblasts are responsible for the formation and organization of bone 
extracellular matrix and its subsequent mineralization. Osteocytes represent terminally 
differentiated osteoblasts and function within networks to support bone structure and 
metabolism. These cells communicate with each other and with the surrounding 
medium through extensions of their plasma membrane. Therefore osteocytes are 
thought to act as mechanosensors, osteoclasts where and when to resorb bone and 
osteoblasts where and when to form it. Osteoclasts are derived from mononuclear 
precursor cells of the monocyte-macrophage lineage. The most functional 
characteristic feature of osteoclasts is their unique ability to dissolve bone mineral, 
which is mainly crystalline hydroxyapatite. In order to finalize bone resorption after 
mineral dissolution they also perform an enzymatic degradation of organic bone 
matrix [18-23].  
Bone is constantly renewed through the balance between bone formation and bone 
resorption. This restructuring process called bone remodeling maintains the integrity 
of the skeleton by removing old bone of high mineral density and high prevalence of 
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fatigue micro-cracks through repetitive cycles of bone resorption performed by 
osteoclasts and bone formation carried out by osteoblasts [14, 24, 25]. Several 
regulatory systems, both systemic and local, are required to keep these two processes 
in balance, and an imbalance between bone resorption and bone formation is often 
linked to metabolic bone diseases [22, 26]. Cellular communication between bone 
cells, as osteoblasts, osteocytes and osteoclasts is essential for bone remodeling, 
comprising a sequence of stages. The activation of resorption is thought to be 
mediated by the death of osteocytes in the neighborhood of a micro-crack. This leads 
to osteoclast precursor recruitment, osteoclastogenesis and bone resorption. After the 
osteoclasts have finished resorbing, they die by apoptosis, and switch between 
resorption and formation called the reversal phase takes place during which osteoblast 
precursors are recruited. After this phase, bone formation is carried out by osteoblasts 
until the resorbed area is rebuilt with new bone, after which the cycle is concluded, a 
process likely to be controlled by osteocytes [22, 25-28].  
Nevertheless, for different reasons such as defects size, infection, and many others, 
injured and diseased bone may not be capable of self-repairing. In such clinical 
circumstances, an appropriate biomaterial should be applied to the defective site to 
substitute lost bone and to initiate bone tissue regeneration. A variety of different 
metals, ceramics and polymers have been used to repair or replace damaged bone 
tissue. Inspired by the hierarchical structure of bone, the combination of materials 
with desirable properties, while at the same time trying to avoid some of their less 
attractive properties, is gaining increasing interest in biomaterials research. Therefore, 
a combination of two or more materials for their favorable properties creates a new 
composite material with a set of unique characteristics that each individual material 
does not meet. Composite materials have gained popularity for bone tissue 
engineering applications because bone is, in fact, a composite material presenting a 
combination of inorganic and organic components. In this sense, composite based on 
apatite crystals and natural polymers have received increasing attention in bone tissue 
engineering due to their ability to biomimetically preserve the structural and biological 
phenotype of the damaged tissues. Remarkably, polymer-ceramic composite scaffolds 
benefit from the joint presence of both biodegradable polymers and bioactive 
ceramics [29, 30].  
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1.2. Biomimetic composites based on polymers and calcium phosphates  
 
The composites involving biodegradable polymeric matrices and bioactive and 
bioresorbable CaPs ceramics have been considered as strategic for tissue engineering 
and regeneration, allowing tailoring the desired degradation and resorption kinetics of 
the matrix. The interest in bioresorbable ceramics, such as calcium phosphates (CaPs) 
(i.e., β-tricalcium phosphate, and to a lesser extent nanohydroxyapatite), for bone 
replacement and repair is well-deserved, given that they have required properties and 
many other attributes that make them excellent candidates for such applications. In 
fact, CaPs present favorable biocompatibility, a composition and structure similar to 
the inorganic phase of bone, and bioactivity. These materials possess surface 
properties that support osteoblast adhesion and proliferation (osteoconduction) and 
stimulate new bone formation (osteoinduction). Moreover, the CaPs with nanosized 
features can strongly change the physical properties of the polymer matrix, generating 
biocomposites with optimized properties when compared to their individual 
components [31-33].  
Biodegradable polymers from natural origin, like polysaccharides (i.e., chitin, cellulose, 
glycosaminoglycans) and proteins (i.e., elastin, collagen, silk), as their name implies, 
are derived from natural sources. The use of natural polymers as scaffolds in bone 
tissue engineering has been gaining widespread attention owing to their significant 
similarities with the extracellular matrix (ECM), biocompatibility, biodegradability, 
chemical versatility, low cost and ease of processing. Among naturally derived 
polymers, silk fibroin provides an important set of material options for biomaterials 
and scaffolds due to its biocompatibility, controllable degradation rate, high oxygen 
and water vapor permeability, and the presence of easily accessible chemical groups 
for functional modifications [31, 34-36].  
 
1.2.1. Silk fibroin   
 
Silks are naturally occurring protein polymers commonly produced by a wide variety of 
insects and spiders. In nature silks are used as materials for web construction and prey 
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capture (spider webs), safety line (draglines) and reproduction enclosures (cocoons) 
[37, 38]. Spider silk is and intriguing material that is lightweight, extremely strong and 
elastic, and it is spun near ambient temperatures and pressures using water as the 
solvent, which gives rise to and environmentally safe, biodegradable material. 
Nevertheless, it is not possible to maintain domesticated spiders to produce massive 
amounts of silk, thus directing our attention to silk fibroin, a mass-producible natural 
protein produced by silkworms [39]. The silkworm Bombyx mori produces silk to 
weave its cocoon, which consists primarily of two protein components, fibroin and 
sericin. Fibroin is the water insoluble structural protein component of silk fibers 
whereas sericin is the water-soluble glue-like protein that holds SF fibers together 
(Figure 2) [37, 39-41]. Silk has several advantages over other protein based 
biomaterials, which are derived from tissues of allogeneic or xenogeneic origins. Also, 
the processing of such materials is expensive due to the stringent protein isolation and 
purification procedures. In contrast, silk fiber purification is routinely carried out using 
a simple alkaline solution based degumming process, which yields the starting material 
for sericin free silk based biomaterials. The degummed silk fibroin is then dissolved in a 
ternary solvent, dialyzed and formed in an aqueous SF solution. Moreover, it is 
economically advantageous to use silk for biomedical applications, because of 
availability of large scale processing infrastructure for traditional silk textile industries 
[31, 35, 42, 43].  
 
 
Figure 2 - Photograph of a Bombyx mori silkworm (A), electron micrograph of partially 
degummed B. mori silkworm cocoon fibers (B) and schematic illustration of the 
composite structure of a cocoon fiber (C), in which the two brins of fibroin and the 
coating of sericins and other proteins postulated to protect the cocoon against 
microbes and predators are pointed out [44]. 
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Silk fibroin (SF) is the core protein which accounts for 70% of the cocoon, and consists 
of two proteins, light chain (Mw approximately 26 kDa) and heavy chain Mw 
approximately 390 kDa), which are present in a 1:1 ration and connected by a disulfide 
link. SF is characterized as natural amphiphilic block copolymer composed of 
hydrophobic (ordered, highly conserved) and hydrophilic (less ordered, relatively more 
complex) blocks. The primary structure of SF consist of a predominance of the amino 
acids glycine, alanine, serine, valine, and tyrosine with characteristic repetitive 
sequences of GAGAGS, GAGAGY, and GAGAGVGY, which are responsible for the 
formation of antiparallel β-sheets in the spun fibers. SF is composed of relatively large 
hydrophilic chain end blocks (N and C-termini) with smaller hydrophilic internal blocks 
and large internal hydrophobic blocks where the repeats listed above are encoded 
(Figure 3). Hydrophilic blocks provide solubility in water and are responsible for SF 
elasticity and toughness, while hydrophobic blocks form intermolecular β-sheet 
structures leading to the insolubility and high strength of SF [40, 41, 43, 45-47].  
 
 
 
Figure 3 - Secondary structure of one B. mori silk fibroin chain (a); (Gly-Ala-Gly-Ala-Gly-
Ser)n amino acid repeat units that self-assemble into antiparallel β-sheets (b) [48]. 
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The molecular conformation of SF is an important parameter that needs to be 
controlled, since it affects its physical and chemical properties. SF has two types of 
molecular conformation of the secondary structure, called silk I and silk II. Silk I is a 
metastable form of SF that is soluble in water and non-crystalline; random coil and α-
helix conformations are usually called silk I. On the other hand, silk II is a highly stable 
and organized structure that is insoluble in water; the β-sheet conformation is called 
silk II (Figure 3). Generally, both silk I and silk II are present in SF products, but it is their 
relative proportions that will define the final properties [49-51]. 
 
The biocompatibility and long-term stability of silk fibroin scaffolds has been shown 
[38]. Recently hydrogel-based scaffolds are gaining attention in the field of tissue 
engineering. Hydrogels have attracted extensive interest because of their 
advantageous properties similar to those of the native extracellular matrix (ECM), such 
as biocompatibility and the ability to absorb high amounts of water or biological fluids 
(up to thousands of times their dry weight) without dissolving in them, thus 
maintaining their three-dimensional (3D) structure and function. Their high 
permeability allows the exchange of oxygen, nutrients, and soluble metabolites [52-
55].  
 
1.2.1.1. Silk fibroin-based hydrogels 
 
Hydrogels are created by the cross-linking of polymer chains, leading to the formation 
of a three-dimensional (3D) network, structurally integral, hydrophilic matrix. 
Hydrogels exhibit solid-like mechanical behavior, with high compliance and elastic 
strain, while consisting mostly of liquid. Hydrogels formed from synthetic polymers 
offer the benefit of gelation and gel properties that are controllable and reproducible 
through the use of specific molecular weights, block structures, and modes of 
crosslinking. Generally, gelation of naturally derived polymers is reported to be less 
controllable. However, the hydrogels formed from natural polymers are more 
compatible for hosting cell and bioactive molecules. Moreover, natural polymers can 
be processed under mild, ambient conditions. The process of gelation occurs when the 
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polymer chains crosslink either chemically or physically into networks, triggered by 
chemical reagents (i.e., cross-linkers) or physical stimulants (i.e., pH, temperature) [48, 
56-59].  
An important advantage of SF for the preparation of hydrogels, compared to other 
polymers, is its ability to physically crosslink without any chemical modification. 
However, to produce SF derived materials, solvents with high ionic strength are used 
to break down the strong hydrogen bonds within the β-sheet molecular structure of 
the silk fibers. These solvents usually contain high concentration of salts that are 
further removed by dialysis. Once the ionic force of the solvent decreases during 
dialysis, SF solution becomes metastable and may undergo a sol–gel transition. The 
hydrogel formation occurs because SF chains tend to aggregate, passing from an 
amorphous conformation (random coil) to a more stable structure (β-sheet). The 
formation of β-sheets acts as physical cross-linking to stabilize the hydrogel and it is 
irreversible under physiological conditions unless degraded by enzymatic or oxidative 
processes. Due to the β-sheet formation, SF exhibit relatively slow degradation in vitro 
and in vivo when compared to collagens and many other biopolymers. This feature 
makes the use of SF, specifically in biomaterial formats for tissue engineering, 
advantageous when compared with most other natural or synthetic polymers, allowing 
the maintenance of the mechanical integrity during new tissue formation. Moreover, 
the degradation products of silk fibroin materials have been shown to be harmless to 
the human body [40, 47, 51, 60-64].  
SF-based composite hydrogels with enhanced physicochemical and biological 
properties have been developed for tissue engineering applications [57, 65]. This 
composite biomaterial can be tailored to meet specific mechanical, functional and 
biological requirements of the host tissues. SF biodegradable polymer can be 
combined with a bioactive ceramic producing a new material for bone implants. SF 
acts as the main structural and tissue component of the hydrogel, providing 
mechanically stable structures that undergo slow biodegradation over extended 
periods of time, while a bioactive ceramic is able to bind the surrounding osseous 
tissue and enhance bone tissue formation, increasing the osteogenic potential of the 
composite hydrogel [34, 66].      
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1.2.2. Hydroxyapatite 
 
The chemical similarity to the mineral component of mammalian bones and teeth has 
fueled the use of calcium phosphates as bone substitute materials. In fact, they can be 
employed with different shapes and functionalities within the clinical area. Ceramics of 
the calcium phosphate family are the most important class of materials in bone 
regeneration and because of the apatitic structure of bone tissue synthetic apatites are 
the most widely studied of all calcium phosphate phases. One of the most widely used 
synthetic calcium phosphate ceramics is hydroxyapatite (HA) due to its chemical 
similarities to the inorganic component of natural bone tissue. Synthetic HA with a 
chemical formula of Ca10(PO4)6(OH)2 and a hexagonal crystalline structure, has a 
theoretical composition of 39.68 wt% Ca, 18.45 wt% P; Ca/P wt ratio of 2.151 and Ca/P 
molar ratio of 1.667. It has higher stability in aqueous media than other calcium 
phosphate ceramics within a pH range of 4.2-8.0 [67-71]. 
HA is a preferred material for bone repair because of its stability under in vivo 
conditions, compositional similarity, biocompatibility, osteoconductivity, bioresorbable 
properties, and ability to promote osteoblasts functions. As a bioactive ceramic HA 
exhibits strong affinity to host hard tissues and the chemical bonding with the host 
tissues offers a greater advantage compared to most other bone substitutes, such as 
allografts or metallic implants [69, 72-75]. 
The recent trend in bioceramics research is shifting towards nanotechnology offering a 
unique approach to overcome shortcomings of many conventional materials and in 
improving their biological properties. The resorption process of synthetic microsized 
HA is different from that of bone mineral. Apatite crystals of bone mineral are in nano-
size with a very large surface area. These crystals are grown in an organic matrix and 
have very loose crystal-to-crystal bonds, and therefore, the resorption of bone mineral 
by the osteoclasts is homogeneous. On the contrary, microsized HA presents a low 
surface area and have strong crystal-to-crystal bonds, which result in a tow stage 
resorption process: disintegration of particles and de-suspension of the crystals. 
Moreover, mineral bone shows higher bioactivity compared to synthetic HA. In this 
sense, nanophased HA presents outstanding functional properties due to its grain size, 
large surface area to volume ratio and ultra-fine structure similar to biological apatite. 
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Consequently, nanosized HA ceramics are expected to have homogeneous resorption 
and better bioactivity than microsized HA. Additionally, nanoHA powders exhibit 
improved and enhanced densification due to their greater surface area, which may 
improve fracture toughness, as well as other mechanical properties [69, 72, 74-76].   
Hydrogels produced from a natural or synthetic polymeric hydrogel matrix, 
incorporating inorganic nanosized HA, can provide not only improved mechanical 
properties, but also tuning the bioactive characteristics to the matrix. For example, 
nanosized HA was incorporated into a poly(ethylene glycol) (PEG) hydrogel matrix. The 
incorporation of nanoHA significantly enhanced the mechanical, physical and chemical 
properties of the nanocomposite. The presence of nanoHA also improved osteoblast 
adhesion when compared with PEG hydrogels [77]. In another study, an injectable and 
thermos-sensitive PEG-poly(ε-caprolactone) (PCL)-PEG copolymer/collagen/nanoHA 
hydrogel composite for guided bone regeneration was developed and the in vivo 
biocompatibility and biodegradability was investigated by implanting the hydrogel 
composite in rats. The results showed that the biodegradable hydrogel composite had 
good biocompatibility and better performance in guided bone regeneration than the 
self-healing process [78].  
 
2. Implant-associated infections 
 
Implant-associated infections in orthopaedics are serious complications with 
consequent devastating effects in bone and in surrounding soft tissues. Depending on 
the nature of the injury or disease, 2-10% of orthopedic hardware facilitates host 
infection with increasing incidences for open fractures, combat-related injuries, and 
revision joint replacements. In addition to human pain and suffering, direct medical 
costs associated with such infections are extremely high and often result in the 
removal of the orthopedic implants and the need for a follow-up operation. Sources of 
infectious bacteria include the environment of the operating room, surgical 
equipment, clothing worn by medical and paramedical staff, resident bacteria on the 
patient’s skin and bacteria already residing in the patient’s body. Although sterilization 
and the use of aseptic techniques greatly reduce the levels of bacteria found in 
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hospital settings, pathogenic microorganisms are still found at the site of 
approximately 90% of all implants [79-82]. 
Implant-associated infections are the result of bacteria adhesion to an implant surface 
and subsequent biofilm formation at the implantation site. In the last twenty years, 
infections caused by bacterial biofilms have reemerged as major health threat. 
Hospital-acquired infections are now responsible for more deaths annually in the 
United States than emphysema, AIDS, Parkinson’s disease, and homicide combined 
and cost the U.S. health care system over $20 billion annually. It is estimated, 
according to the National Institutes of Health, that biofilms contribute to more than 
80% of bacterial infections in humans leading the Centers for Disease Control to 
declare biofilms among the most pressing clinical impediments of the century [81, 83, 
84]. 
 
2.1. Pathogenesis and microbiology 
 
Implant-associated infections occur either by direct inoculation of microorganisms into 
the surgical wound during surgery or immediately thereafter (perioperative infection); 
by microbial spread through blood or lymph from a distant focus of infection 
(hematogenous infection); or by contiguous spread from an adjacent infectious focus 
(contiguous infection). Early and delayed infections are predominantly acquired during 
implant surgery and caused by highly or less virulent organisms, respectively, whereas 
late infections are predominantly acquired by hematogenous seeding from remote 
infections [85-87]. 
A very large proportion of all implant-related infections are caused by staphylococci 
(roughly four out of five), and two single staphylococcal species, respectively 
Staphylococcus aureus and Staphylococcus epidermidis, account together for two out 
of three infection isolates. They represent, in absolute, the main causative agents in 
orthopedics, while CoNS species other than S. epidermidis, and, especially among 
them, Staphylococcus hominis and Staphylococcus haemolyticus, contribute to an 
additional 13% of the infections. In order of relevance in terms of prevalence then 
there follow Pseudomonas aeruginosa and Enterococcus faecalis [88-90]. 
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2.2. Processes governing biofilm formation 
 
Biofilm formation is commonly considered to occur in three main stages: attachment 
to a surface, proliferation and formation of the characteristic, mature biofilm 
structure, and finally detachment, which is also often called dispersal (Figure 4) [91, 
92]. 
 
 
Figure 4 – Phases of biofilm development, which include initial attachment, 
maturation, and final detachment. Attachment may occur directly to a surface or to a 
“conditioning film” formed by host proteins. Then, biofilm maturation proceeds via the 
agglomeration of cells, which is dependent on adhesive molecules. Formation of the 
characteristic channel-containing biofilm structure is dependent on disruptive factors, 
which also ultimately facilitate the last phase of biofilm development, detachment 
[92].  
 
Initial bacterial attachment can occur on abiotic or biotic surfaces. Attachment to an 
abiotic surface is dependent on the physicochemical characteristics of the material and 
bacterial surfaces. This type of attachment is thus driven mostly by hydrophobic or 
electrostatic interactions. However, the involvement of specific bacterial surface 
molecules in this process, such as the surface protein autolysin or teichoic acids, has 
been described in staphylococci. Attachment to a biotic surface such as human tissue 
is governed by entirely different, much more specific interactions. Staphylococci 
express a large variety of surface-anchored proteins that bind to host matrix proteins, 
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collectively called MSCRAMMs (microbial surface components recognizing adhesive 
matrix molecules). These interactions are of vital importance for biofilm-associated 
infections on biomedical implants, as such implants become covered by a conditioning 
film consisting of host plasma and connective tissue proteins and glycoproteins (such 
as fibronectin, vitronectin, fibrinogen, albumin, and immunoglobulins) soon after 
insertion. Many of these proteins subsequently serve as specific receptors for 
colonizing microorganisms or incoming mammalian cells [80, 91-94].  
Biofilm maturation comprises adhesive processes that link bacteria together during 
proliferation and disruptive processes that form channels in the biofilm structure. In 
staphylococci, arguably the most important adhesive biofilm molecule is an 
exopolysaccharide named polysaccharide intercellular adhesin (PIA). Together with 
other polymers such as teichoic acids and proteins forms the main part of what has 
often been called “slime”, the extracellular matrix of biofilm-forming staphylococci. 
DNA released from lysed bacteria, called extracellular DNA (eDNA), also forms part of 
that network. As in the case of teichoic acids, the negative charge of DNA may play a 
crucial role in interacting with other surface structures. The disruptive processes are 
necessary for nutrients to reach cells in deeper biofilm layers, indicating that biofilm 
maturation requires cell-cell-disruptive factors. Quorum-sensing (QS), a regulatory 
mechanism in microorganisms that controls gene expression in a cell-density-
dependent manner, has received much attention as a regulator of biofilm formation 
and maturation. In addition to biofilm structuring, disruptive processes also ultimately 
cause the detachment of cell clusters from a biofilm, which controls biofilm expansion 
and has important consequences for in vivo biofilm infection, as it may lead to 
systemic dissemination. Particularly in staphylococci, biofilm maturation was also 
proposed to occur by enzymatic degradation of biofilm matrix components most 
notably by proteases and nucleases. Detached biofilm bacteria may establish 
secondary biofilm infections elsewhere, possibly with increased severity, such as for 
example endocarditis [79, 91-93]. 
Free floating planktonic bacteria without a surrounding biofilm are normally accessible 
to appropriate systemic antibiotics. However, biofilm formation and persistence has 
profound implications for the patient, because microorganisms growing as biofilms are 
significantly more resistant to antibiotic treatment (up to 1000-fold) and host 
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defenses. The most important innate host defense mechanism is the elimination of 
bacteria by phagocytes. Activation of these immune cells depends on the recognition 
of pathogen-associated molecular patterns, but these may also be hidden by matrix 
components that do not themselves trigger phagocyte activation efficiently. Moreover, 
prolonged use of antibiotics at higher doses to treat such infections may lead to drug 
resistance systemic and local toxicity, and potentially compromise bone growth, 
immune system surveillance and implant osseointegration [79, 80, 91, 93, 95-97]. 
Therefore, the preparation of multifunctional materials with the ability of repairing 
bone tissue, while preventing bacterial adhesion and subsequent biofilm formation at 
the implantation site, should be an important breakthrough in bone disease 
treatments.  
 
2.3. Strategies for fighting bacterial infections 
 
The quest to design and fabricate new antibacterial surfaces as an integral component 
of advanced biomaterials remains a high research priority. In order to eliminate or 
substantially reduce the extent of bacterial adhesion and biofilm formation on the 
surfaces, intensive efforts have been focused on the production of new antimicrobial 
biomaterials [98]. 
Antimicrobial surfaces can be distinguish between passive and active depending on 
whether there are antibacterial agents delivered locally. Passive surfaces do not 
release bactericidal agents to the surrounding tissues; these surfaces rely on inhibition 
of bacterial adhesion and/or kill bacteria upon contact. Passive surfaces are preferred 
as long as their antibacterial ability is strong enough to prevent biofilm formation. 
However, the effectiveness of such surfaces is limited and varies greatly depending on 
bacterial species. Also, the physicochemical properties of the surface can be masked 
by an adsorbed conditioning film of host proteins, thereby diminishing their 
effectiveness. In contrast, active surfaces are designed to release pre-incorporated 
bactericidal agents (i.e., antibiotics, silver ions, and peptides) immediately following 
the implantation to downregulate infection even in the presence of a surface-adsorbed 
protein layer [99-101]. 
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Biomaterials endowed with anti-infective properties need to be tailored according to 
the specific application. The following sections describes various strategies developed 
to generate such biomaterials and the specific stimuli that are used to trigger 
antibacterial action. Anti-adhesive surfaces, surfaces with anti-infective organic agents, 
and surfaces with anti-infective inorganic agents are considered. 
 
2.3.1. Anti-adhesive surfaces 
 
The earliest step in the pathogenesis of foreign-body-related infections is bacterial 
adhesion. There is obviously no possibility for colonization to occur if bacteria cannot 
adhere to a solid surface. Anti-adhesive surfaces prevent bacteria attachment due to 
the presence of an unfavourable surface topography and/or chemistry with respect to 
the microorganisms. Clearly, bacterial adhesion in protein-free solution can be 
prevented by anti-adhesive surfaces that do not need to take into account protein 
behaviour and protein surface conditioning. In most cases, however, the devices are in 
contact with protein-rich solutions varying in composition depending on the anatomic 
site of application of the medical device. Therefore, the protein film rapidly formed on 
the biomaterial surface during the initial exposure to physiologic fluids should also be 
considered, since various host proteins mediate the bacterial adhesion through the 
interaction with bacterial adhesins [98, 102]. Poly(ethylene glycol) (PEG) functionalized 
surfaces have been demonstrated to drastically reduce protein adsorption, due to the 
formation of an interface layer that prevents direct contact between the surface and 
protein, thereby reducing bacterial colonization of the surface [103, 104]. Therefore, 
conditioning protein-surfaces and/or protein-bacteria interactions are good strategies 
to inhibit bacterial adhesion to a specific biomaterial. Low adhesiveness of these 
surfaces is certainly a great advantage for catheters, but in other internal applications 
could possibly hinder tissue adhesion and integration of the implant, since many 
surfaces that inhibit bacterial adhesion also limit mammalian cell adhesion, which is 
desired for osteogenesis and implant success. Therefore, since both infection 
prevention and osseointegration are requirements for a successful implant, it is 
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necessary to focus specifically on strategies able to inhibit bacterial colonization and 
concomitantly promote cell functions.   
 
2.3.2. Surfaces with anti-infective organic agents 
 
Controlled release of antibiotics are powerful therapeutic tools and effectively 
eradicate bacterial contamination. A large number of studies have investigated the 
efficacy of surfaces coated with covalently linked antibiotics [105-107]. However, high 
local antibiotic concentrations are only achieved over the short term. While controlled 
release of antibiotics provide an effective treatment of acute infection, at late 
treatment times surviving bacteria can slowly re-establish a biofilm that may lead to 
bacterial dissemination. Moreover, high levels of antibiotics may lead to tissue toxicity, 
compromising bone growth and implant osseointegration. Also, the effectiveness of 
surfaces with antibiotics is strongly dependent on the spectrum of activity of the 
chosen drug, and the possibility of development of antimicrobial resistance in a 
relatively short time period [108, 109].  
Antimicrobial peptides (AMPs) are an extremely interesting group of anti-infective 
agents and currently sought as the next generation of antibiotics. AMPs are an integral 
part of the innate immune system of all multicellular organisms to protect them 
against invading microorganisms [110-112]. Most AMPs are small (12-50 amino acids), 
have a positive charge, and an amphipathic structure enables them to interact with 
bacterial membranes. AMPs have a broad spectrum of antimicrobial activity (against 
Gram-positive and negative bacteria, fungi, parasites, enveloped viruses, and even 
multidrug-resistant microorganisms) and possess low propensity for developing 
resistance. With their amphipathic nature, they directly act on the membrane of the 
pathogen. Cationic AMPs interact by electrostatic forces with the negatively charged 
surface of microbial membranes, namely, lipopolysaccharides in Gram-negative and 
teichoic acids in Gram-positive bacteria, causing disruption of bacterial membrane 
integrity [113-119]. AMPs may represent excellent coating agents with broad spectrum 
antimicrobial activity for preventing implant-associated infections [120-122]. Despite 
many attractive attributes, potential systemic and local toxicity, sensitization and 
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allergy after repeated application, susceptibility to proteases and pH changes, high 
manufacturing costs, constitute the main limitations associated to the use of AMPs 
[115, 117].  
Recently, molecules and compounds that interfere with the expression of various 
bacterial phenotypes have shown great premise. Bacterial behavior within biofilms is 
regulated by the phenomenon of QS, where bacteria release chemical signals and 
express virulence genes in a cell density dependent manner. Different types of QS 
signals, also known as autoinducers (AIs), are involved in QS such as oligopeptides in 
Gram-positive bacteria and N-acyl-homoserine lactones (AHLs) in Gram-negative 
bacteria. Since QS is responsible for virulence in the clinically relevant bacteria, 
inhibition of QS appears to be a promising strategy to control these pathogenic 
bacteria. The interference with the microbial QS system by quorum quenching (QQ) is 
a potential approach that may lead to the development of the next generation anti-
infective agents based on interfering with bacterial communication to block QS-
mediated pathogenic infection. In particular, diverse QQ agents have been identified 
from various sources and organisms. All of the QQ agents may be classified into two 
groups according their molecular weight, small molecular and macromolecular QQ 
agents, which are also referred to as QS inhibitors and QQ enzymes, respectively. This 
QQ strategy does not aim to kill the pathogen or limit cell growth but to shut down the 
expression of the pathogenic gene. Thus, since the QQ approach does not affect the 
survival of the pathogen, it could avoid the appearance of resistances, which has been 
proposed as one of the main advantages of QQ strategies [123-128]. Nevertheless a 
recent study has demonstrated that QQ compounds can generate resistance in P. 
aeruginosa [129]. 
 
2.3.3. Surfaces with anti-infective inorganic agents 
 
Recently, the confluence of nanotechnology and biology has brought to fore metals in 
the form of nanoparticles (NPs) as potent antimicrobial agents. Inorganic NPs with 
antimicrobial activity have been the center of research due to their physicochemical 
properties that can be exploited to promote remarkable applications in biomedicine. 
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High surface area to volume ratio of the NPs enhances their interaction with microbes 
leading to the upsurge in the research on NPs and their potential application as 
antimicrobials [130, 131]. The exact mechanisms for antibacterial effect of metallic 
nanoparticles are still being investigated but two more popular proposed possibilities 
include free metal ion toxicity arising from dissolution of the metals from surface of 
the NPs (i.e., Ag+ from AgNPs) and oxidative stress via the generation of reactive 
oxygen species (ROS) on surfaces of the NPs [132]. Among metallic NPs, silver and gold 
nanoparticles gained importance as novel antimicrobial agents due to their strong 
antimicrobial properties against a wide range of microorganisms including multidrug-
resistant bacteria.  
Silver nanoparticles are the most widely used nanomaterial in healthcare today. AgNPs 
have been shown to be effective against a wide array of pathogens, such as fungi, 
viruses, and many bacterial species [133-135]. It has also been showed that AgNPs are 
potential antimicrobial agents against drug-resistant bacteria [136]. These superior 
antimicrobial, antifungal, and antiviral properties of AgNPs mean that are frequently 
present in coatings for bone implants, medical devices, catheters, and dental 
composites [137, 138]. The mechanisms underlying AgNPs microbial toxicity remain 
the subject of intense debate. Both contact killing and/or ion mediated killing have 
been proposed as the action mechanism of antimicrobial activity of AgNPs. The 
mechanism of silver ions release was showed by Xiu Z et al. where the toxicity of the 
AgNPs was explained by the presence of released Ag+ [139]. The action mechanism of 
silver ions is still not completely understood, but there are some hypothesized 
mechanisms, mainly regarding direct Ag+-induced membrane damage, Ag+-related ROS 
production, and cellular uptake of Ag+ ions, with consequent disruption of ATP 
production and hindering of DNA replication activities [140]. Nevertheless, the 
antimicrobial activity of AgNPs cannot be attributed solely to the released Ag+ ions but 
also to the nanoparticle itself [141, 142]. The AgNPs have the ability to attach to the 
bacterial cell membrane, and also penetrate inside the bacteria causing damage by 
interacting with phosphorous- and sulfur-containing compounds like DNA. The NPs 
preferably attack the respiratory chain and cell division that finally lead to cell death 
[138].  
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Gold nanoparticles also have recently attracted a lot of attention because of their 
biocompatibility [143]. Additionally, the antimicrobial activity of AuNPs has been 
recently reported [144-146]. The exact mechanism of bacterial growth inhibition has 
not been elucidated yet, however some reports present the bacterial wall damage as 
the cause of the bacterial cell death. The AuNPs can interact with the functional groups 
on the bacterial cell surface to inactive bacteria and destroy them [147, 148].  
Inorganic metal oxide nanoparticles, such as zinc oxide (ZnO) and titanium dioxide 
(TiO2), are also being explored and extensively investigated as potential antimicrobials 
[131, 149]. The antimicrobial properties of zinc oxide-containing nanoparticles are 
mediated by the strong adherence of ZnO NPs to bacterial cell membranes and 
destruction of lipids and proteins of the membrane, resulting in a leakage of 
intracellular contents and eventually the bacterial cell death. In addition, generation of 
hydrogen peroxide and Zn+2 ions, which damage the bacterial cell, were suggested to 
be key antibacterial mechanisms of ZnO NPs [133, 150, 151]. Titanium dioxide-
containing nanoparticles are the most studied for photocatalytic antimicrobial activity 
among various NPs. In a process called photocatalysis, TiO2 NPs generates reactive 
oxygen species (ROS), including hydrogen peroxide and hydroxyl radicals, upon 
exposure to ultraviolet (UV) light. Then ROS damage bacterial cell membranes, thereby 
compromising membrane semipermeability, interfering with oxidative 
phosphorylation, and sometimes causing cell death [133, 152].   
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Abstract 
 
Silk fibroin has been widely explored for many biomedical applications, due to its 
biocompatibility and biodegradability. The aim of this work was to study the role of 
dialysis and freezing on structural conformation, thermal properties and morphology 
of silk fibroin hydrogels. Hydrogels were prepared after 3 and 7 days of dialysis and the 
effect of freezing was analyzed. For that purpose, a part of the fibroin hydrogels 
underwent freezing at -20 °C for 24 hours, followed by lyophilization and the rest of 
the hydrogels were kept at 8 °C for 24 hours, with further lyophilization. The fibroin 
hydrogels were characterized by X-ray diffraction (XRD), Fourier transformed infrared 
spectroscopy (FTIR), thermogravimetric analysis (TGA) and scanning electron 
microscopy (SEM). Measurements by XRD and FTIR indicated that silk I and silk II 
structures were present in the fibroin hydrogels and that the secondary structure of 
fibroin is transformed mostly to β-sheet during the gelation process. Thermal analysis 
indicated that fibroin hydrogels are thermally stable with the degradation peak at 
around 330-340 °C. SEM micrographs showed porous structures and the fibroin 
hydrogels subjected to freezing presented a much larger pore size. Results indicate 
that the dialysis time and freezing did not alter the material crystallinity, conformation 
or thermal behavior; however, hydrogel microstructure was strongly affected by 
dialysis time and freezing, showing controlled pores size. This study provides 
fundamental knowledge on silk fibroin hydrogels preparation and properties and the 
studied hydrogels are promising to be used in the biomaterial field. 
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Introduction  
 
Replacement of functional tissues requires the development of three-dimensional (3D) 
scaffolds that can provide an optimum microenvironment for tissue growth and 
regeneration [1, 2]. Pore architecture in 3D polymeric scaffolds is known to play a 
critical role in tissue engineering as it provides the growth, adhesion, migration and 
proliferation of cells. Therefore, the scaffolds should have suitable properties such as 
interconnecting network of pores for the effective migration, growth and attachment 
of cells, sufficient porosity for the effective transport of nutrients and waste, 
biocompatibility, and biodegradation properties, for being exploited in tissue 
engineering applications [3]. 
Silk fibroin (SF) derived from Bombyx mori silkworm is a structural protein which 
possesses many important properties for tissue engineering and regenerative 
medicine, such as versatile processing, slow biodegradation, good biocompatibility, 
low immunogenicity, low inflammatory response, adjustable mechanical properties, 
high permeability to oxygen and water vapor and resistance to enzymatic degradation 
[4-6]. 
The cocoon of the silkworm is mainly composed of two protein components, fibroin 
and sericin. Fibroin is the water insoluble structural protein component of silk fibers 
whereas sericin is the water-soluble glue-like protein that holds SF fibers together [4]. 
Since the sericin contamination was identified to be the main source of problems, such 
as unwanted immunological reactions in vivo [7, 8], purified SF has become a novel, 
promising biomaterial and has found increasing numbers of applications in clinical 
devices including in tissue engineering of cartilage, bone, muscle, ligament and tendon 
tissues [9-13]. Fibroin is the core protein which accounts for 70% of the cocoon and is a 
hydrophobic glycoprotein [4]. SF consists mainly of the amino acids glycine, alanine 
and serine which form antiparallel β-sheets in the spun fibers and provide stability and 
interesting mechanical properties to the fibers [4, 14]. SF can assume distinct 
conformations; α-helix and random-coil conformations (also called silk I) and the β-
sheet conformation (silk II). Silk I is a metastable form that is soluble in water and silk II 
is insoluble in water and is the most stable structure, where SF chains are connected 
by hydrogen bonds between the adjacent segments of polypeptide chains [5, 15-17]. 
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SF fibers, extracted from B. mori cocoons, are insoluble in water and in the majority of 
organic solvents. SF dissolves in concentrated acid solutions and in concentrated 
aqueous, organic and aqueous-organic salts solutions [18]. These solutions contain 
highly concentrated salts that need to be removed by dialysis in order to prepare SF-
based materials, such as hydrogels [19], films [17] and nanoparticles [20]. SF solution 
after dialysis is metastable (predominance of silk I) and it can easily convert to a more 
stable form, by a conformational transition to silk II, forming stable hydrogels. SF 
gelation from aqueous solution is a kinetic process and depends on factors such as SF 
concentration, temperature, pH [21] and presence of other materials, such as poly(N-
isopropylacrylamide) [22] and poly(ethylene oxide) polymers [23]. SF gelation process 
is also influenced by dialysis parameters, since the rate of salt removal will directly 
influence the conformational transition of SF. The rate of salt removal can influence SF 
conformational transition, since the salt is responsible for SF solvation and stabilization 
in solution. When salt is removed, a metastable solution is obtained and at this point 
gelation is just a kinetic process. If the necessary amount of salt is not removed during 
dialysis, SF-based materials cannot be prepared due to the strong salt solvation. On the 
contrary, the more salt is removed, the more rapid is the gelation process [19]. Thus, 
dialysis is a key parameter on SF gelation and the study of dialysis time is important to 
define SF hydrogels properties. 
Cryogenic processes, based on freezing of hydrogels, and subsequent lyophilization, 
are widely used for scaffold preparation because of the biocompatibility of both the 
template and the process for template removal [24-26]. During the freezing step, 
solvent crystals grow at a controllable rate and solute molecules are excluded from the 
frozen solvent until the sample is completely frozen. The freezing step is very 
important in order to produce desirable porous structures, with control over the pores 
size and quantity, depending on parameters such as freezing temperature and rate 
[27]. 
The purpose of the present study was to study the role of dialysis and freezing on 
structural conformation, thermal properties and morphology of silk fibroin hydrogels. 
Hydrogels were prepared after 3 and 7 d of dialysis and the effect of freezing was 
analyzed. The structure and properties of SF hydrogels were determined by X-ray 
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diffraction (XRD), Fourier transformed infrared spectroscopy (FTIR), thermogravimetric 
analysis (TGA) and scanning electron microscopy (SEM). 
 
 
Results  
 
Crystallinity 
Figure 1 shows the X-ray diffractograms of SF hydrogels prepared from SF solution 
subjected to different dialysis time and freezing. The halos at 2θ = 20.4°, 2θ = 20.2°, 2θ 
= 20.7° and 2θ = 20.6° appearing in the XRD spectra of SF hydrogels formed at 37 °C 
after 3 d of dialysis subjected to freezing (Fig. 1A), SF hydrogels formed at 37 °C after 3 
d of dialysis kept at 8 °C (Fig. 1B), SF hydrogels formed at 37 °C after 7 d of dialysis 
subjected to freezing (Fig. 1C) and SF hydrogels formed at 37 °C after 7 d of dialysis 
kept at 8 °C (Fig. 1D), respectively, are attributed to the silk II (β-sheet) conformation 
[14, 20, 28-30]. 
 
 
Figure 1. X-ray diffractograms of SF hydrogels formed at 37 °C after 3 d of dialysis 
subjected to freezing (A) or kept at 8 °C (B) and SF hydrogels formed after 7 d of 
dialysis subjected to freezing (C) or kept at 8 °C (D). 
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Structural conformation  
By analyzing the infrared spectrum, the structural conformation of SF can be 
determined, depending on the wavenumber location of the absorption bands of 
amides I, II and III. Amide I, II, and III bands are attributed to C = O stretching, N-H 
deformation, and O-C-N bending, respectively [31]. 
The infrared spectra of the SF hydrogels are shown in Figure 2. The SF hydrogel formed 
at 37 °C after 3 d of dialysis and subjected to freezing (Fig. 2A) presented absorption 
bands at 1625 cm-1 (amide I) and 1525 cm-1 (amide II), corresponding to the silk II 
structural conformation [32-34]. Other adsorption band was observed at 1234 cm cm-1 
(amide III), which is characteristic of the silk I conformation [35]. 
 
 
Figure 2. FTIR-ATR spectra of SF hydrogels formed at 37 °C after 3 d of dialysis 
subjected to freezing (A) or kept at 8 °C (B) and SF hydrogels formed after 7 d of 
dialysis subjected to freezing (C) or kept at 8 °C (D). 
 
The SF hydrogel formed at 37 °C after 3 d of dialysis and kept at 8 °C (Fig. 2B) showed 
adsorption bands at 1631 cm-1 (amide I) and 1533 cm cm-1 (amide II), indicating the 
existence of the silk II structural conformation [32-34]. The adsorption band at 1240 
cm-1 (amide III) is characteristic of the silk I conformation [36]. 
The SF hydrogels formed after 7 d of dialysis subjected to freezing or not (Fig. 2C and 
D, respectively) presented similar spectra, with adsorption band at 1635 cm-1 (amide I) 
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corresponding to the SF silk II structural conformation [32-34]. The adsorption bands at 
1525 and 1527 cm-1 (amide II), for SF hydrogels formed after 7 d of dialysis subjected 
to freezing or not (Fig. 2C and D, respectively), is also attributed to the SF silk II 
structural conformation [32, 34]. The adsorption band at 1234 cm-1 (amide III), for both 
SF hydrogels formed after 7 d of dialysis is ascribed as silk I structural conformation 
[35]. 
In all the analyzed hydrogels the co-existence of silk I and silk II conformations was 
observed, which is typical of SF hydrogels. 
 
Thermal analysis  
Thermogravimetric curves of SF hydrogels are shown in Figure 3. The thermograms of 
all samples showed similar trend. The initial weight loss of SF hydrogels at around 100 
°C is due to loss of water. The second weight loss took place within the temperature 
range between 270 and 380 °C and is associated with the breakdown of side chain 
groups of amino acid residues as well as the cleavage of peptide bonds [37, 38]. 
 
 
Figure 3. TGA curves of SF hydrogels formed at 37 °C after 3 d of dialysis subjected to 
freezing (A) or kept at 8 °C (B) and SF hydrogels formed after 7 d of dialysis subjected 
to freezing (C) or kept at 8 °C (D). 
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For observation of SF hydrogels degradation peaks, derivate of the thermogravimetric 
curves were analyzed, as shown in Figure 4. It is possible to observe that all samples 
presented similar behavior, with a peak at around 330–340 °C, which is attributed to 
the thermal degradation of SF hydrogels. 
 
 
Figure 4. DTGA wide scan curves of SF hydrogels and detected degradation peaks 
(inset) in all hydrogels. SF hydrogels formed at 37 °C after 3 d of dialysis subjected to 
freezing (A) or kept at 8 °C (B) and SF hydrogels formed after 7 d of dialysis subjected 
to freezing (C) or kept at 8 °C (D). 
 
Morphology 
Figure 5 shows the micrographs of the SF hydrogels porous structure obtained by SEM. 
These revealed that all samples had 3D morphologies with uniform porous structures 
and they showed the effect of freezing on SF hydrogels formed at 37 °C after 3 d of 
dialysis (Fig. 5A) and SF hydrogels formed after 7 d of dialysis (Fig. 5C), which were 
frozen at -20 °C for 24 h, compared with the SF hydrogels kept at 8 °C (Fig. 5B and D). 
The SF hydrogels subjected to freezing presented a pore size much larger than the 
hydrogels kept at 8 °C. Moreover, it is possible to see that the SF hydrogels formed 
after 7 d of dialysis kept at 8 °C showed a thicker fibroin network with smaller pores 
(Fig. 5D) than SF hydrogels formed after 3 d of dialysis (Fig. 5B). 
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Figure 5. SEM micrographs of the porous structure SF hydrogels formed at 37 °C after 
3 d of dialysis subjected to freezing (A) or kept at 8 °C (B) and SF hydrogels formed 
after 7 d of dialysis subjected to freezing (C) or kept at 8 °C (D). 
 
 
Discussion 
 
Significant work has been performed over the last decade to develop natural polymers 
for biomedical applications, particularly for biocompatible implantable materials [39]. 
Among natural polymers, silk is an interesting candidate component for tissue 
engineering. The goal of this research was to study the role of dialysis and freezing on 
structural conformation, thermal properties and morphology of silk fibroin hydrogels. 
The SF solution, before dialysis, is supersaturated and can be stored without 
undergoing gelation for several months. This happens due to the high ionic strength 
that promotes SF fibers solvation. During the dialysis, the salt ions diffuse from SF 
solution into the dialysis water and the ionic force decreases. This allows more 
interaction between SF molecules and the solution may undergo a sol-gel transition 
[19]. 
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Through X-ray diffraction measurement, some information about SF crystalline 
structure and its conformations of silk I and silk II can be obtained from its crystal 
structure transition. The distinct halos found in the X-ray diffractograms at 2θ = 20.4°, 
2θ = 20.2°, 2θ = 20.7° and 2θ = 20.6° for SF hydrogels presented typical patterns of β-
sheet structure (silk II). Previous studies by Kim et al. presented that all hydrogels 
prepared in your work showed a distinct halo at 2θ = 20.6°, which is attributed to β-
sheet crystalline structure of SF [14]. Kundu et al. observed a halo at 2θ = 20.2° 
denoting the silk II structure appeared in the XRD pattern of the SF nanoparticles made 
from B. mori protein [20]. Kim et al. observed a halo at 2θ = 20.4° for SF scaffolds 
indicating that is a β-sheet crystalline structure (silk II) [28]. Lv et al. showed the 
presence of the diffraction halo at 2θ = 20.7° in silk fibroin films, corresponding to β-
sheet structure [30]. This β-sheet conformation is formed during SF solution gelation, 
as a result of SF molecular chain dehydration and their intra and intermolecular 
hydrogen bond formations. In solution, SF molecules are predominantly organized into 
the α-helix and random coil structure. However, this structure tends to convert to the 
β-sheet upon hydrogel formation, which is thermodynamically more stable [40]. No 
remarkable differences were observed in the XRD spectra of the SF hydrogels formed 
under different conditions within this study. 
FTIR spectroscopy is very sensitive to conformational modifications of silk fibroin. Each 
SF crystalline form shows a specific absorption band in distinct vibrational regions 
associated with the amide groups in proteins. The more interesting infrared bands to 
analyze proteins are the amide bands: amide I, amide II and amide III [31]. Results of 
FTIR investigation showed that there were slight shifts of the adsorption bands of 
amides but without conformational changes. This indicates that SF presented in the 
hydrogel is highly stable and does not change its conformation due to changes in 
external factors. 
Thermal decomposition of SF is mainly influenced by the intrinsic morphological and 
physical properties of the protein [41, 42]. The results obtained by TGA suggest that SF 
hydrogels thermal degradation occurs at 330–340 °C, which according to the literature 
is related to SF materials with crystalline β-sheet (silk II) conformation [42, 43]. This 
result is in agreement with the XRD result, which determined that the secondary 
structure of SF hydrogels is predominantly β-sheet (silk II). By FTIR analysis was 
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possible to verify the presence of silk I conformation on the amide III absorption band, 
indicating that this structure may occur in the fibroin hydrogels, but in a lower 
proportion when compared with the silk II. 
Morphology of SF hydrogels, reveled by SEM micrographs, indicates the presence of a 
porous structure with three-dimensional interconnectivity [14, 43-47]. The SF 
hydrogels subjected to freezing (-20 °C) showed larger pore size when compared with 
SF hydrogels kept at 8 °C. The SF hydrogels kept at 8 °C were frozen with liquid 
nitrogen before the lyophilization. In the lyophilization procedure, pore size of the 
material is controlled by the size of the ice crystals formed during freezing. The 
freezing process with liquid nitrogen is particularly rapid and, ideally, the water 
presented within the pores of the hydrogel turns into ice crystals that sublimate during 
lyophilization, maintaining the same shape and size of the pores of the hydrogel. 
However, when the freezing process is performed at a higher temperature, such as 
freezing at -20 °C, ice nucleation is slow and the nuclei tend to grow into larger ice 
crystals, which leads to the generation of materials with large and random pores [48]. 
The porous features resulting from freezing are in good agreement with precise 
results. Guan et al. showed that when polyurethane scaffolds were frozen in liquid 
nitrogen small pores were observed and most of the pores were less than 10 μm in 
size [49]. Chun et al. observed that the pore size of porous poly(D,L-lactic-co-glycolic 
acid) scaffolds frozen at liquid nitrogen temperature was smaller than 5 μm, but the 
pore size was enlarged up to 30–50 μm when frozen at -20 °C for 24 h [50]. Similarly, 
Ma et al. observed that when the temperature was decreased from -20 °C to -196 °C 
(liquid nitrogen) the pore size of poly(L -lactic acid) scaffolds was greatly decreased 
from 115–140 µm to 20–40 µm [51]. Chung et al. also showed that the pores of 
alginate/galactosylated chitosan scaffolds formed after liquid nitrogen treatment were 
small than the pores formed after freezing at -20 °C and -70 °C [52]. 
Other processes for the preparation of porous materials include: solvent 
casting/particulate leaching [38], emulsion templating [39] and phase separation [40]. 
In general, these methods require the use of large amounts of organic solvents and a 
lengthy washing or etching procedure [38, 42, 43]. A freezing process can provide 
certain advantages over the traditionally used techniques cited above [44]. Water is an 
environment-friendly solvent and the use of ice crystals as porogens is green and 
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sustainable. This is particularly beneficial for biological applications. When removing 
the solvent, the freezing process does not bring impurities into the samples and a 
further purifying process is therefore not necessary. 
 
 
Materials and Methods  
 
Preparation of silk fibroin solution 
Cocoons of Bombyx mori silkworm were supplied by Bratac. To obtain pure SF fibers 
from silkworm cocoons it was necessary to perform a degumming process of silk 
cocoons to remove the sericin coating. This process was achieved by initially washing 
the cocoons with distilled water to remove any impurity, followed by the immersion of 
cocoons in 1 g/L of Na2CO3 solution at 85 °C for 1 h and 30 min, with solution change 
every 30 min. A final wash in distilled water was done to remove Na2CO3 residues. The 
SF fibers were dried and dissolved in a ternary solvent of CaCl2:CH3CH2OH:H2O, in a 
molar ratio of 1:2:8, at 85 °C until total dissolution, to a SF salt solution of 10% (w/v) 
[17]. 
 
Preparation of fibroin hydrogels 
We studied two different methods for the preparation of fibroin hydrogels. In the first 
method, SF solution at a concentration of 10% (w/v) was dialyzed (cellulose 
membrane, Viscofan 22 EU – 20 USA) against distilled water for 3 d, at 8 °C, with water 
change every 24 h. After dialysis, the solution was filtered by gauze to remove small 
amounts of aggregates. The final concentration of the silk fibroin aqueous solution was 
4% (w/v), which was determined by weighing the remaining solid after drying. The 
dialyzed solution was placed on specific molds (diameter: 25 mm) in a thermostatic 
bath at 37 °C until the formation of gels (3 d). Hydrogel formation was observed when 
the sample presented an opaque white color and did not fall when the mold was 
inverted for 30 s [14, 53]. Cylinder-shaped samples sized 25 mm in diameter and 10 
mm in thickness were used. The SF hydrogels were then subjected to a freezing at -20 
°C for 24 h. To analyze the effect of freezing, control samples of SF hydrogels were kept 
at 8 °C for 24 h. 
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In the second method, SF salt solution in a concentration of 10% (w/v) was dialyzed 
(cellulose membrane, Viscofan 22 EU – 20 USA) against distilled water at 8 °C, with 
water change every 24 h, until the formation of hydrogels inside the dialysis tube (7 d). 
The influence of freezing on this hydrogels was also analyzed by freezing SF hydrogels 
at -20 °C for 24 h, while the control samples (non-frozen hydrogels) were kept at 8 °C 
for 24 h. 
Four different types of samples were prepared: 1) dialysis for 3 d followed by hydrogel 
formation at 37 °C and freezing by 24 h at -20 °C; 2) dialysis for 3 d followed by 
hydrogel formation at 37 °C and kept at 8 °C for 24 h; 3) dialysis for 7 d until hydrogel 
formation inside the tube and freezing by 24 h at -20 °C and 4) dialysis for 7 d until 
hydrogel formation inside the tube and kept at 8 °C for 24 h. 
All hydrogels were characterized after freezing by liquid nitrogen and lyophilization 
(Liobras, L101, Brazil) within the first 24 h to prevent structural changes. 
 
Characterization 
 
X-ray Diffraction 
Changes in the crystallinity of hydrogels were followed with X-ray diffraction (XRD), 
performed by a X'Pert-MPD diffractometer (Philips Analytical X Ray) with Cu-Kα 
radiation, with a wavelength of 1.54 Å. The X-ray source was operated at 40 kV and 40 
pA. The scanning speed was 0.06°/s, step size of 0.02°, and the measurement range 
was 2θ = 10–40°. Three samples were used for each type of material. 
 
Fourier Transformed Infrared Spectroscopy 
The structural changes of silk fibroin hydrogels were analyzed in the range of 675–
4000 cm-1, with a resolution of 4 cm-1, using Fourier transformed infrared spectroscopy 
with attenuated total reflection apparatus (FTIR-ATR) (Nicolet 6700, Thermo Scientific). 
FTIR was used to identify the secondary structure of the protein samples through the 
location of the peaks of amide I, II and III. Three samples were used for each type of 
material. 
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Thermogravimetric Analysis 
Thermogravimetric analysis (TGA) measurements were performed on the hydrogels 
using a thermogravimetric analyzer (TGA-50, Shimadzu) in the temperature range of 
30–600 °C with a slope of 10 °C/min and a N2 flow of 50 mL/min, in order to analyze 
the influence of dialysis and freezing on the weight loss of the samples with respect to 
the temperature. Three samples were used per each type of material. 
 
Scanning Electron Microscopy 
The cross-section morphology of fibroin hydrogels was observed by scanning electron 
microscopy (SEM). The analysis was performed on the lyophized samples coated with a 
gold layer and then examined with an EVO MA15 scanning electron microscope (Zeiss), 
at 200× and 5000× magnification, with an accelerating voltage of 10 kV. 
 
 
Conclusions 
 
The present work describes the formation and characterization of silk fibroin 
hydrogels. Three-dimensional silk fibroin hydrogels were successfully prepared with an 
interconnected porous structure. From the results of X-ray diffraction and FTIR-ATR 
analysis, it is concluded that SF transforms into β-sheet after gelation, and both silk I 
and silk II structures exist simultaneously in all hydrogels. Thermal analysis showed the 
degradation peak for all SF hydrogels at around 330–340 °C, indicating high thermal 
resistance for these hydrogels. Longer dialysis time (7 d) resulted in a thicker fibroin 
network after lyophilization, showing that the dialysis time has an effect on the 
material porous structure and morphology. The effect of freezing was also visible on 
the porous structure of SF hydrogels, considerably increasing pore sizes. These 
scaffolds may hold promise in bone tissue engineering, and the degradation rate of the 
SF porous structures and in vitro citocompatibility tests are subject of future work. 
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Abstract 
 
This work presents a novel composite hydrogel consisting of silk fibroin (SF) and 
nanohydroxyapatite (nanoHA) prepared by a new and innovative method using 
ethanol as gelling agent capable of forming hydrogels in few minutes. The properties 
of the composite material, such as the microstructure as well as the chemical and 
physical properties were studied. Moreover in vitro studies of osteoblastic 
citocompatibility were performed. The microporosity and macroporosity obtained 
combined with interconnected porous structure and a uniform dispersion of nanoHA 
particles throughout the fibroin matrix makes composite hydrogel suitable for bone 
regeneration. The compression modulus of composite hydrogels was increased as the 
nanoHA concentration increased from 10 to 15 wt% and the water uptake ability of 
these materials decreased with the incorporation of nanoHA. The metabolic and 
alkaline phosphatase activities of osteoblastic cells were improved with the 
incorporation of nanoHA in the SF matrix providing a more promising material for bone 
tissue engineering.  
 
Keywords: bone tissue engineering; hydrogel; silk fibroin; nanohydroxyapatite; 
biocomposite 
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1. Introduction 
 
Bone tissue engineering has emerged as a promising alternative in cases of bone loss, 
overcoming problems of rejection and donor scarcity associated to the clinical used 
bone grafts [1, 2]. By combining three-dimensional structures (3D) - scaffolds, cells and 
growth factors, bone tissue engineering seeks to achieve a long lasting and fully 
functional regeneration of bone [3]. Materials with high hydrophilic properties appear 
suitable for mimicking the aqueous in vivo environment. For this reason, hydrogels 
have been used extensively as 3D matrices [4]. They represent promising systems for 
the healing and regeneration of damaged tissues since they are highly permeable and 
facilitate the transport of nutrients and metabolites [4]. Their ability to mimic body 
tissues and respond to external stimuli has made them important and promising forms 
of biomaterials for various applications including tissue engineering, controlled drug 
release devices, etc. [5]. Current research on biodegradable polymers is emerging, 
combining these structures with osteogenic cells, as an alternative to autologous bone 
grafts. Different types of biodegradable materials have been proposed to be used as 
3D porous scaffolds for bone tissue engineering. Among them, natural polymers are 
one of the most attractive options, mainly due to their similarities with extracellular 
matrix (ECM), chemical versatility, good biological performance and inherent cellular 
interactions [6]. The unique properties of silk fibroin (SF), a protein polymer isolated 
from the cocoons of the domestic silkworm Bombyx mori, such as slow 
biodegradation, adjustable mechanical properties, low inflammatory response, high 
permeability to oxygen and water vapor, resistance to enzymatic degradation, 
favorable processability in combination with biocompatibility, have driven wide 
interest in this material for a variety of applications, ranging from textiles to 
biomedical use [7-10]. Based on these features, interest has arisen in the use of 
Bombyx mori SF as starting material for biomaterials and scaffolds for bone tissue 
engineering. The cocoon of the silkworm is mainly composed of sericin and fibroin. 
Sericin is a glue-like protein that holds SF fibers together in the cocoon case. SF is 
composed of a repetitive sequence of amino acids: glycine, alanine and serine, and is 
not soluble in water due to its high concentration of hydrophobic amino acids [7]. SF 
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has two types of molecular conformation of the secondary structure, called silk I and 
silk II. Silk I is a metastable form of SF that is soluble in water and non-crystalline; 
random coil and α-helix conformations are usually called silk I. On the other hand, silk 
II is a highly stable and organized structure that is insoluble in water; the β-sheet 
conformation is called silk II. Generally, both silk I and silk II are present in SF products, 
but it is their relative proportions that will define the final properties [11-13]. Due to 
the β-sheet formation, SF exhibits relatively slow degradation in vitro and in vivo when 
compared to collagens and many other biopolymers [7, 14]. The biodegradability, 
mechanical integrity and low inflammatory response of SF [15] ensure its role as one of 
the promising porous materials for osteogenic applications. In addition, studies 
demonstrate that SF scaffolds are able to induce calcium phosphate deposition in in 
vitro calcification experiments, demonstrating that SF is a promising scaffold for bone 
regeneration [16, 17]. We hypothesize that the incorporation of nanosized HA particles 
(nanoHA) into biodegradable SF hydrogels should improve osteogenic outcomes. 
Hydroxyapatite [HA, Ca10(PO4)6(OH)2] is one of the most widely used synthetic calcium 
phosphate ceramics due to its chemical similarities to the inorganic component of hard 
tissues and it possesses exceptional biocompatibility, bioactivity and osteoconductivity 
[18-22]. Some studies have indicated that nanostructured materials may promote 
increased specific protein interactions to more efficiently stimulate new bone growth 
compared to conventional materials [23, 24]. NanoHA shows increased potential to 
bind to bone, to adsorb macromolecules that may act in the preliminary events leading 
to bone bonding and tissue regeneration [25, 26]. The aim of this work was to develop 
a novel composite hydrogel for bone tissue engineering of silk fibroin and nanoHA, an 
approach that has been poorly explored. The hydrogels were prepared by a new and 
innovative method, which can be used to form hydrogels in few minutes, using ethanol 
as gelling agent. The focus of the present study was to accelerate the formation of 
hydrogels without occurrence of nanoHA aggregation or sedimentation. The attributes 
of SF in combination with the features of nanoHA will form a material with interesting 
properties, combining the mechanical integrity and slow degradation of SF with the 
bioactivity and osteoconductivity of the nanoHA. 
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2. Materials and Methods 
 
2.1.  Preparation of silk fibroin solution 
Cocoons of Bombyx mori silkworm were supplied by Bratac (São Paulo, Brazil). The 
cocoons were degummed three times by soaking in 1 g/L of Na2CO3 solution at 85 °C 
for 30 min to remove the sericin of the cocoons, and then rinsing in distilled water to 
remove Na2CO3 residues. The SF fibers were dried and dissolved in a ternary solvent of 
CaCl2:CH3CH2OH:H2O, in a molar ratio of 1:2:8, at 85 °C until total dissolution, to a SF 
salt solution of 10% (w/v). The SF salt solution was then dialyzed (cellulose membrane, 
Viscofan 22 EU – 20 USA) against distilled water for 3 days, at 8 °C, with water changes 
every 24 hours [27]. The final concentration of the SF aqueous solution was 4% (w/v), 
which was determined by weighing the remaining solid after drying. 
 
2.2.  Preparation of silk fibroin/nanoHA composite hydrogels 
For preparing the SF/nanoHA hydrogels, a total of 3.5 mL of SF aqueous solution was 
placed in specific molds (diameter: 25 mm). The dry powder of nanoHA aggregates 
(Fluidinova S.A., Maia, Portugal) was first mixed with 1.5 mL of 70% ethanol and then 
slowly mixed with the SF aqueous solution using a pipet to avoid protein precipitation. 
The weight percent (wt%) of nanoHA in the hydrogels was 0, 10, 15, 20 and 30. The 
hydrogels were named according to their nanoHA content. SF/nanoHA hydrogels were 
prepared at two temperatures. The molds were sealed and kept at a controlled 
temperature in a thermostatic bath at 37 or 50 °C until hydrogel formation. Gelation 
time was determined when the sample showed an opaque white color and did not 
flow when the mold was inverted for 30 s [28, 29]. Part of these hydrogels was frozen 
at -20 °C for 24 h to evaluate differences in the properties of non-frozen and frozen 
hydrogels. These hydrogels were identified with the letter F. Moreover, since fibroin is 
a natural polymer, the gelation time was evaluated from SF solutions prepared in 
different days to evaluate the reproducibility of the materials and to find a highly 
reproducible method for the formation of hydrogels. The data reported for gelation 
time represent the average of ten replicates for each temperature. 
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2.3.  Characterization 
 
2.3.1.  Morphology 
Morphology of non-frozen and frozen hydrogels was characterized by scanning 
electron microscopy (SEM). The analysis was performed on samples that were frozen 
with liquid nitrogen, lyophilized, coated with a gold layer and then examined with an 
EVO MA15 scanning electron microscope (Zeiss, England), with an accelerating voltage 
of 10 kV. The average pore size of the materials was determined from SEM images 
using ImageJ software by selecting ten arbitrary areas by measuring approximately 200 
pores for each material.  
 
2.3.2.  Mechanical analysis 
The mechanical properties of hydrogels were measured by confined compression test 
using a SMS (Stable Micro Systems, Surrey UK) TA-xT2 texturometer equipped with a 1 
kg load cell at room temperature. The compression limit was 500 g to protect the load 
cell and the speed test was 0.2 mm/s. Cylinder-shaped samples sized 25 mm in 
diameter and 10 mm in thickness were used. To minimize the effect of water 
evaporation, hydrogel samples were kept in sealed packs before measurement. The 
compressive stress and strain were graphed and the average compression modulus 
and standard deviation were determined. The compression modulus was calculated by 
determining the slope of the linear region in the 7.5%-15% of strain in the stress–strain 
curve. The data reported were the mean of five samples. 
 
2.3.3.  Crystallinity 
The crystallinity of hydrogels was followed with X-ray diffraction, performed by a 
X'Pert-MPD diffractometer (Philips Analytical X Ray, Netherlands) with Cu-Kα radiation, 
with a wavelength of 1.54 Å. The X-ray source was operated at 40 kV and 40 pA. The 
scanning speed was 0.06°/s, step size of 0.02° and the measurement range was 2θ=10-
60°.  
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2.3.4.  Molecular conformation 
The secondary structure of hydrogels was investigated by Fourier transformed infrared 
spectroscopy (FTIR) with a Perkin-Elmer 2000 FT-IR spectrometer. Measurements were 
performed with pressed discs made using potassium bromide (KBr) powder. The FTIR 
spectra were collected between the wavenumber of 4000–400 cm-1, with a resolution 
of 4 cm−1 and with one hundred scans accumulated per sample. 
 
2.3.5.  Thermal Properties 
The thermal properties of SF/nanoHA hydrogels were examined using a 
thermogravimetric analyzer (TGA-50, Shimadzu, Japan) in the temperature range of 
30-600 °C with a ramp rate of 10 °C/min and a N2 flow of 50 mL/min.  
 
2.3.6.  Swelling Properties 
The swelling capacity studies were performed at room temperature by immersing the 
dried hydrogels in distilled water for 1 h. Different time intervals were selected to 
measure the weight of the hydrated hydrogels after swelling. During weight 
measurements, the samples were first removed from the aqueous solution and gently 
dried with a filter paper to remove the excess solvent. At least five samples with 
similar weight (ca. 10 mg) were used for each type of hydrogel. The swelling degree of 
the hydrogels was determined by using the following equation:  
 
SD (%) = [(Ws-Wd)/Wd]×100 
 
where Ws and Wd were the weights of the swollen and the dry sample, respectively. 
 
2.4.  In vitro biological studies 
 
2.4.1.  Cell culture 
Hydrogel sections with 7 mm diameter and 5 mm thickness were sterilized in ethanol 
solution at 70% (v/v). Osteoblast-like cells (MG63 cell line) were cultured in minimum 
essential medium (MEM) Eagle, alpha modification (α-MEM) containing 10% fetal 
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bovine serum, 100 IU/mL penicillin,/2.5 µg/mL streptomycin, (Gibco, UK) and 2.5 
µg/mL amphotericin B (Gibco, UK), and 50 µg/mL ascorbic acid ( Sigma, USA). The 
cultures were incubated in a humidified atmosphere of 95% air and 5% carbon dioxide 
(CO2) at 37 °C. At 70 – 80% confluence, the adherent cells were washed with PBS and 
detached with trypsin solution (0.04%, Gibco, UK) at 37 °C for 10 min and counted 
using a hemocytometer.  Previous to the cell seeding, the samples were incubated 
with complete culture medium for 30 min at 37 °C in a humidified atmosphere of 95% 
air and 5% CO2. Then, the culture medium was completely removed from the 
hydrogels. Afterward, cells were seeded at a density of 1×105 cells/scaffold on the top 
of the hydrogels, and tissue culture polystyrene (TCPS) plates were used as control. 
Moreover, the SF hydrogels were used as controls of the SF/nanoHA hydrogels. All 
samples were cultured for 3 different time points (1, 4 and 7 days).  
 
2.4.2.  Resazurin assay 
At each time point, the metabolic activity was evaluated by the resazurin assay. The 
same sample was followed throughout the culture time, i.e. it was assessed at all time-
points. The resazurin is a simple and non-reactive assay, where a non-fluorescent blue 
component is reduced by the living cells to a pink fluorescent component. Fresh 
medium with 10% (v/v) of resazurin was added to the cells, which were incubated at 
37 °C in a humidified atmosphere of 95% air and 5% CO2 for 3 h. Then, 100 µL were 
transferred to a 96-well plate and the fluorescence intensity was measured in a 
microplate reader (Synergy HT, BioTek, USA) at 535 nm excitation wavelength and 590 
nm emission wavelength. The data reported were the average of three samples. 
 
2.4.3.  Confocal laser scanning microscopy 
Cells were fixed with 3.7% formaldehyde (Sigma-Aldrich) for 15 min and then washed 
twice in PBS. Then, the materials were incubated for 30 min with 0.1% (v/v) Triton X-
100 solution (Sigma-Aldrich) and 30 min with 1% bovine serum albumin solution in PBS 
(BSA, Sigma-Aldrich). Osteoblast-like cells were stained for F-actin cytoskeleton with 
alexafluor phalloidin 594 (Invitrogen) in 1% BSA solution for 30 min at room 
temperature. Samples were washed twice with PBS and nuclei were stained with DAPI 
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(40-6-diamidine-2-phenylindole, Invitrogen) for 10 min. Finally, the materials were 
washed twice with PBS and the morphology was evaluated with a Spectral Confocal 
Microscope Leica TCS-SP5 AOBS (Leica). 
 
2.4.4.  Alkaline phosphatase activity and protein content 
At each time point, colonized hydrogels were washed twice in PBS and they were 
placed at 37 °C and 5% CO2 for 1 h with 0.5 mL of ultrapure water. Subsequently, they 
were placed in a freezer at -80 °C and then thawed at room temperature to lyse the 
cell membranes. Alkaline phosphatase (ALP) activity was assayed by the hydrolysis of 
p-nitrophenol phosphate (Sigma), in alkaline buffer solution, 2-amino-2-methyl-1-
propanol (Sigma), at pH 10.5. After 1 h of incubation at 37 °C, the reaction was stopped 
by adding NaOH (5M, Sigma), and the hydrolysis product (p-nitrophenol) was 
measured at 405 nm, using a plate reader (BioTek). ALP activity was normalized to 
total protein content and was expressed as nanomoles of p-nitrophenol produced per 
minute per microgram of total protein (nmol min-1/µg protein). Total protein content 
was measured by Lowry’s method with bovine serum albumin used as a standard. 
 
2.5.  Statistical analysis 
The results were expressed as the average ± standard deviation (SD). The statistical 
analysis of the results was carried out using the one-way analysis of variance (ANOVA) 
followed by post hoc Tukey HSD multiple comparison test. Levels of p < 0.05 were 
considered to be statistically significant. 
 
 
3. Results  
 
3.1.  Preparation of SF/nanoHA composite hydrogels 
Initial experiments showed that the hydrogel of pure SF takes 67 h and 48 h to 
complete the gelation process under 37 °C and 50 °C, respectively. This long time to 
complete the gelation process prompt us to develop a new method to accelerate the 
formation of SF/nanoHA hydrogels without nanoHA aggregation and/or 
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sedimentation. For that, ethanol was used as gelling agent for SF as well as a 
dispersion agent for nanoHA. Ethanol concentrations of 30, 50, 70, 80, 90 and 100% 
were tested. Interestingly, for ethanol concentrations in the SF solution higher than 
70%, large amounts of fibroin precipitated. For concentrations lower than 70%, 
deposition of nanoHA was observed. This occurred because, at this condition, SF 
solution took more than 15 minutes to gelify and it was found that the maximum time 
for the formation of hydrogels without nanoHA deposition was 15 minutes. The dry 
powders of nanoHA aggregates were mixed with the ethanol solution in a particular 
ratio. However, when the nanoHA content was higher than 15 wt%, nanoHA 
aggregation occurred. The SF/nanoHA ratios chosen for this work were 90:10 and 
85:15 wt%. SF hydrogels without nanoHA were used as controls. 
Table 1 shows the gelation time of SF/nanoHA hydrogels, in the presence of 70% 
ethanol, with respect to temperature and concentration of nanoHA. The use of 70% 
ethanol allowed the formation of hydrogels within 15 minutes without nanoHA 
deposition or SF precipitation. The gelation time of SF/nanoHA hydrogels was similar 
for both temperatures.  
 
Table 1. Gelation time of SF/nanoHA hydrogels, in the presence of 70% ethanol, with 
respect to temperature and concentration of nanoHA. Values are average ± SD. 
Temperature (°C) nanoHA wt% Gelation Time (min) 
37 
0 7.6 ± 1.2 
10 6.0 ± 0.8 
15 7.3 ± 1.0 
50 
0 6.9 ± 1.0 
10 6.3 ± 1.2 
15 6.5 ± 1.1 
 
 
 
 
 
72 
 
3.2.  Characterization of silk fibroin/nanoHA hydrogels  
 
3.2.1. Morphology and porosity 
Morphology and porosity of hydrogels were analyzed by SEM. Pores between 1.0 and 
264.2 µm were measured by the Image J software (Fig. 1).   
 
Fig. 1. Pore diameter and pore size distribution of non-frozen and frozen SF and 
SF/nanoHA composite hydrogels. Pore dimensions were grouped, from 0 to over 100 
µm. Pore diameter values are average ± SD. 
 
The pore sizes of hydrogels prepared at 37 °C and 50 °C were similar and therefore 
only SEM images concerning to materials prepared at 37 °C are shown. The 
incorporation of nanoHA into SF solution at 37 °C and 50 °C increased the average pore 
sizes. The frozen hydrogels showed higher pore sizes when compared to the non-
frozen hydrogels. Pore size distribution in all the hydrogels is also shown in Fig. 1. The 
SF hydrogels only presented pores between 0 and 20 µm. All the others hydrogels 
showed a heterogeneous pores distribution. 
Figs. 2 and 3 show the SEM images of non-frozen and frozen SF and SF/nanoHA 
hydrogels, respectively. SEM observations revealed a uniform porous structure within 
SF hydrogels (Fig. 2(a) and (b)). The SF/nanoHA composite hydrogels exhibited an 
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irregular porous structure (Fig. 2(c) and (d)), which indicate that nanoHA addition 
influenced the hydrogels porous structure.  
 
Fig. 2. SEM images of non-frozen SF hydrogels (a and b) and SF/nanoHA15 composite 
hydrogels (c and d).  
 
The frozen SF hydrogels also presented an irregular porous structure indicating the 
influence of freezing on the porous structure (Fig. 3(a) and (b)). The frozen SF/nanoHA 
hydrogels also revealed an irregular porous structure (Fig. 3(c) and (d)). Similar porous 
structure was observed for SF/nanoHA nanocomposite hydrogels containing 10 and 15 
wt% of nanoHA, implying that this variation in nanoHA content did not alter the 
microstructure of the material. Therefore, only SEM images of SF/nanoHA composite 
with 15 wt% of nanoHA are shown. The high magnification SEM micrographs showed 
an interconnected 3D structure (Figs. 2(b), (d) and 3(b), (d)) and non-agglomerated 
distribution of nanoHA aggregates within the SF matrices (Fig. 2(d) and 3(d)). 
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Fig. 3. SEM images of frozen SF hydrogels (a and b) and frozen SF/nanoHA15 
composite hydrogels (c and d).  
 
3.2.2.  Mechanical properties 
The effect of the nanoHA particles incorporation on the compression modulus of the 
composite hydrogels prepared at 37 °C is presented in Fig. 4A. The addition of 10 wt% 
of nanoHA caused a decrease of compression modulus in composite hydrogels 
compared to the SF hydrogels. However, the compression modulus of hydrogels 
increased from 92.2 kPa to 109.8 kPa as the nanoHA concentration increased from 10 
to 15 wt%. The frozen SF hydrogels presented lower compression modulus than non-
frozen SF hydrogels. Nevertheless, the compression modulus of frozen composite 
hydrogels showed increasing values with the increase in nanoHA content, namely 65.4 
kPa, 92.4 kPa and 111.6 kPa when the nanoHA concentration was 0, 10 and 15 wt%, 
respectively. Additionally, the materials presented similar mechanical properties for 
both temperatures (Fig. 4(B)).  
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Fig. 4. Compression modulus of (A) non-frozen and frozen SF and SF/nanoHA 
composite hydrogels prepared at 37 °C; and (B) non-frozen and frozen SF hydrogels 
and SF/nanoHA15 composite hydrogels prepared at 37 °C and 50 °C. Different 
uppercase letters indicate intragroup significant differences (p<0.05) according to 
Tukey HSD. * Intergroup significant differences (p<0.05) according to Tukey HSD. 
Values are average ± SD. 
 
Therefore, the hydrogels prepared at 37 °C were chosen for the following 
characterizations, since they were prepared in a mild temperature (requiring lower 
energy) and had similar gelation time (Table 1), pore size (Fig. 1) and mechanical 
resistance to compression (Fig. 4(B)) when compared to the hydrogel prepared at 50 
°C. Also, we choose to continue the experiments with the SF/nanoHA hydrogels with 
15 wt% of nanoHA because of the improved mechanical properties and higher amount 
of bioactive agent, in combination with adequate pore sizes for bone tissue 
engineering.  
 
3.2.3.  Structural analysis 
The obtained XRD patterns of hydrogels are shown in Fig. 5A. The distinct halo at 
2θ=20.4° for pure SF material (Fig. 5A(a)) was attributed to the silk II form, indicating 
that the secondary structure conformation is β-sheet [30]. The SF hydrogels prepared 
with ethanol (Fig. 5A(b)) presented the same halo that the pure SF material at 
2θ=20.4°, showing that the ethanol did not affect the crystallinity of the material. The 
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frozen SF hydrogels (Fig. 5A(c)) also showed the same halo that the pure SF material at 
2θ=20.4°, showing that the freezing process did not affect the crystallinity of the 
material. The existence of 2θ halos, for nanoHA aggregates (Fig. 5A(f)), at 25.9°, 31.9°, 
34°, 39.8°, 46.7°, 49.5° and 53.2° correspond to the diffraction planes (002), (211), 
(202), (310), (222), (213) and (004) of the HA crystallites, respectively [31, 32]. The XRD 
patterns of the non-frozen and frozen composite hydrogels simultaneously exhibited 
characteristic halos from silk II structure and nanoHA aggregates (Fig. 5A(d) and (e)). 
No halo shifts was observed when the nanoHA was added to the SF, indicating that the 
incorporation of nanoHA did not change the crystallinity of SF in the hydrogel. Three 
clear diffraction halos corresponding to the (002), (211) and (310) planes of nanoHA 
crystals were detected in the SF/nanoHA materials. Moreover, these three halos 
became slightly broader and weaker when compared with pure nanoHA aggregates.  
 
Fig. 5. X-ray diffraction patterns (A), FTIR spectra (B), thermogravimetric curves (C) and 
differential thermogravimetric curves (D) of pure SF hydrogels (a), SF hydrogels (b), 
frozen SF hydrogels (c), SF/nanoHA15 hydrogels (d), frozen SF/nanoHA15 hydrogels (e) 
and pure nanoHA (f). 
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The FTIR spectrum of pure SF material (Fig.5B(a)) presented typical amide bands of 
fibroin, that is, 1627 cm-1 was ascribed to amide I (C=O stretching) and 1525 cm-1 to 
amide II (N-H deformation), indicating the existence of the SF silk II structural 
conformation [33-35]. The band at 1233 cm-1 was ascribed to amide III (O-C-N 
bending), which is characteristic of the silk I conformation [36]. This indicates that silk I 
and silk II structures are presented simultaneously in pure SF hydrogels. The 
absorption bands of amide I, amide II and amide III of SF hydrogel prepared in the 
presence of ethanol were also centered at 1627 cm-1, 1525 cm-1 and 1233 cm-1, 
respectively, showing that the ethanol did not affect the structural conformation of SF 
(Fig. 5B(b)). The frozen SF hydrogel also presented the same absorption bands, 
showing that the freezing process did not affect the structural conformation of SF (Fig. 
5B(c)).  The spectrum of pure nanoHA aggregates (Fig. 5B(f)) presented typical 
absorption bands of HAs. The presence of phosphate (PO43-), hydroxyl (OH-) and H2O 
groups was confirmed by the FTIR spectrum in nanoHA aggregates. The bands 
centered at 1028 cm−1, 962 cm−1, 602 cm−1, 564 cm−1 and 472 cm−1 were due to the 
molecular vibrations of phosphate group. The band at 1028 cm−1 corresponded to v3 
mode vibration of PO43- and the band at 962 cm−1 corresponded to v1 mode vibration 
of PO43-, whereas bands at 604 and 565 cm−1 were due to v4 mode vibration of PO43- 
and the band at 472 cm−1 was due to v2 mode vibration of PO43-. The band of hydroxyl 
group appeared at 631 cm−1. The band at 875 cm-1 (v2 vibration) is due to carbonate 
group [19, 37, 38]. A broadband was observed at 3200–3600 cm-1, which indicated 
adsorbed water on the materials. The spectra of non-frozen and frozen SF/nanoHA 
hydrogels (Fig. 5B(d) and (e)) showed all major bands of SF and nanoHA. 
 
3.2.4.  Thermal properties 
Themogravimetric analysis (TGA) and differential thermogravimetric (DTGA) curves of 
nanoHA, SF hydrogels, and SF/nanoHA hydrogels are shown in Fig. 5C and D. The non-
frozen and frozen SF hydrogels and composite hydrogels presented an initial weight 
loss below 100 °C and, as a temperature is increased, the second weight loss started to 
decrease sharply at above 200  °C (Fig. 5C(a)-(c)). In addition, the thermal behavior of 
the composite hydrogels was similar to SF probably due to its higher content in the 
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composites (Fig. 5C(d) and (e)). There was no significant weight loss of pure nanoHA 
when the temperature raised from 30 °C to 600 °C (Fig. 5C(f)). Fig. 5D presents the 
differential thermogravimetric curves for the hydrogels. The non-frozen and frozen SF 
and SF/nanoHA composite hydrogels presented similar behavior, with peaks of 
thermal degradation around 300 °C. 
 
3.2.5.  Swelling behavior 
The most important property of a hydrogel is its ability to absorb and hold an amount 
of solvent in its network structure. It was observed that water swelling of hydrogels 
occurred rapidly (Fig. 6), reaching equilibrium of water uptake in approximately 10 
min. The addition of nanoHA in the polymeric matrix decreased the swelling degree of 
SF/nanoHA hydrogels. Moreover, the frozen hydrogels presented higher swelling 
capacity.  
 
Fig. 6. Swelling degree for non-frozen and frozen SF hydrogels and SF/nanoHA 
composite hydrogels. Values are average ± SD. 
 
3.3.  Citocompatibility and ALP activity of SF/nanoHA composite hydrogels 
The metabolic activity of the osteoblast-like cells MG63 in the hydrogels was evaluated 
by the resazurin assay. SF hydrogels without nanoHA were used as controls. Resazurin 
assay was performed on days 1, 4, and 7 of cell seeding to monitor the metabolic 
activity, and the data are shown in Fig. 7.  
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Fig. 7. Metabolic and ALP activities of MG63 osteoblast-like cells cultured on non-
frozen and frozen SF/nanoHA15 hydrogels, using non-frozen and frozen SF hydrogels 
as control, respectively. * Significant differences (p<0.05) from the respective control 
at the same culture time. ** Significant differences (p<0.05) between non-frozen and 
frozen hydrogels. Data are presented as the average ± SD. 
 
The metabolic activity of MG63 cells with frozen SF/nanoHA hydrogels was significant 
increased at all time-points when compared with to the respective control. However, 
for the non-frozen hydrogels a significant increase in metabolic activity was only 
observed at day 7. Moreover, the frozen hydrogels exhibited significantly higher 
metabolic activity than non-frozen hydrogels at all time-points. SF and SF/nanoHA 
composite hydrogels were observed by CLSM at day 7 (Fig. 8). Both types of hydrogels 
allowed the attachment and spreading of the cells, which showed an elongated 
morphology with well-defined nuclei and cell-to-cell contacts. In addition, cell 
distribution within the porous hydrogels was evident. Results presented in Figs. 7 and 
8 support the compatibility of these 3D hydrogels. 
The functional activity of the MG63 osteoblast-like cells on hydrogels was assessed by 
ALP activity. Fig. 7 showed that ALP activity increased with culture time on non-frozen 
and frozen SF/nanoHA hydrogels. These results also revealed an enhanced osteogenic 
response, as measured by ALP expression, for composite hydrogels at day 7. 
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 Fig. 8. CLSM images of osteoblastic cells at day 7 on SF hydrogels (a), frozen SF 
hydrogels (b), SF/nanoHA15 composite hydrogels (c) and frozen SF/nanoHA15 
composite hydrogels (d). MG63 cells were stained for F-actin cytoskeleton with 
phalloidin (red) and nuclei with DAPI (blue). 
 
 
4. Discussion 
 
This study reports the development of a SF/nanoHA composite hydrogel by a new and 
innovative approach using ethanol as gelling agent, a method able of forming 
hydrogels in few minutes. This occurs because the conformational change of SF from 
81 
 
random coil to β-sheet structure was accelerated by the ethanol due to the 
dehydration of SF chains, allowing more interactions among SF molecules. 
The SF/nanoHA hydrogels and frozen SF and SF/nanoHA hydrogels exhibited both 
microporosity and macroporosity structure with interconnected pores. These features 
are important for cell attachment and proliferation, cell-matrix interactions, 
vascularization, diffusion of nutrients and metabolites and in vivo bone ingrowth [39-
41]. Studies in the literature report that pore sizes >50 µm have been shown to be 
favorable to new bone formation, whereas the minimum pore sizes for 
osteoconduction is thought to be 80-100 µm [42-44]. According to Sopyan et al [45] 
and Chang et al [46] biomaterials with pore sizes between 50 and 150 μm improve 
vascularization and cellular viability as well as formation of new bone tissue. 
Moreover, the distribution of nanoHA particles in the network of SF/nanoHA 
composite hydrogels is very important and will determine the properties of materials. 
The SEM images of hydrogels showed that nanoHA particles were homogenously 
dispersed and embedded throughout the SF structure without aggregation, indicating 
a good interaction between SF and nanoHA.  
Pore size is also an important factor governing mechanical properties. The decrease 
observed in compression modulus for composite hydrogels with 10 wt% of nanoHA 
and frozen SF hydrogels, compared to SF hydrogels, could be attributed to the increase 
in pore sizes as well as the formation of an irregular porous structure. In scaffolds with 
small pore sizes the load gets distributed evenly throughout the surface to resist 
compression. Well-connected small pores form a barrier and do not allow the crack to 
propagate easily [47]. Moreover, other researchers reported that more uniform pore 
structure in scaffolds improved mechanical properties of the polymer matrices [48, 
49]. The compression modulus of non-frozen and frozen composite hydrogels 
increased with the nanoHA concentration, from 10 to 15 wt%. Considering that the 
pore structure in the SF/nanoHA hydrogels is not uniform, the increase of mechanical 
properties of the composite hydrogels should be attributed to the higher nanoHA 
content. On the other hand, it should be emphasized that the compression modulus of 
the composite hydrogels was higher than that reported earlier for fibroin based 
hydrogels [50, 51]. 
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By correlating the XRD and FTIR results, it is possible to state that the prepared non-
frozen and frozen SF/nanoHA composite hydrogels possess a structure predominant of 
silk II and both analyses confirm the existence of nanoHA particles in the composite. 
Moreover, by XRD analysis it was observed that these composite hydrogels presented 
broader halos with lower intensity than pure nanoHA aggregates, suggesting that 
nanoHA particles modulated by the polymer have small crystallite sizes and low 
crystallinity, similar to natural bone minerals [52, 53]. The thermal degradation 
behavior of the non-frozen and frozen composite hydrogels was divided into two 
stages. The first one, below 100 °C, is related to the water evaporation, while the 
second stage, above 200 °C, is associated with the breakdown of side chain groups of 
amino acid residues as well as the cleavage of peptide bonds of SF (Fig. 5C(a)-(c)) [17, 
54]. These materials were thermally stable with thermal degradation around 300 °C. 
All the hydrogels showed high water uptake ability starting the swelling rapidly in the 
first 10 min and this behavior is a characteristic response that has been observed with 
porous and hydrophilic materials. The incorporation of nanoHA decreased the swelling 
of SF/nanoHA network, perhaps due to the lower water uptake ability of nanoHA 
compared to SF protein. Thein-Han and Misra also described a decrease in the swelling 
degree by addition of nanoHA aggregates to chitosan scaffolds [55]. Similarly, Peter et 
al studied chitosan-gelatin/nanohydroxyapatite composite scaffolds and observed that 
the addition of nanoHA decreased the water uptake capacity [56]. Moreover, the 
swelling degree was higher for frozen hydrogels and this behavior could be explained 
by the higher pore sizes for these hydrogels as compared to non-frozen hydrogels. This 
trend is in agreement with previously reported observations. Kim et al observed that 
the swelling ratio of the SF scaffolds decreased gradually with a decrease in pore size 
[30]. Mandal et al also observed that SF/polyacrylamide hydrogels presented a higher 
swelling ratio compared to pure polyacrylamide based hydrogels due to the larger 
diameter of the pores of the composite hydrogels [57]. Swelling and porosity aid in the 
supply of nutrients to the interior of the composite scaffolds and also increase the 
surface area for the cells to adhere that is essential for tissue engineering scaffolds. 
But increased swelling affects the mechanical property of the material, thus a 
controlled swelling is appreciated for any tissue engineering application, indicating that 
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the SF/nanoHA composite hydrogels are more adequate when compared to the SF 
hydrogels [56].  
SF/nanoHA hydrogels are intended to be implanted at small bone defects in order to 
accelerate the rate of bone healing and regeneration. For that, the scaffold has to be 
biocompatible, facilitate cell proliferation and should not elicit a body immune 
response. To assess biological properties of hydrogels, these were seeded with MG63 
osteoblastic cells. Resazurin assay revealed higher cell metabolic activity in the 
composite materials with nanoHA compared with SF hydrogels and, additionally, cell 
ingrowth was well evident on the porous composite scaffolds. Since it is well 
established that HA is bone-bioactive, SF/nanoHA hydrogels would have a high affinity 
for bone cells. It was reported that the addition of HA to polycaprolactone and poly(L-
lactic acid) polymers could improve the cell viability and activity [58]. ALP activity, a 
common indicator of the expression of osteoblastic phenotype [59], was higher on the 
composite hydrogels, showing the efficiency of the nanoHA aggregates in enhancing 
the osteoblastic phenotype expression level. These findings indicate that these 
composites hydrogels are able to improve the functional activity of the bone-derived 
cells. Moreover, as the HA is an osteoconductive material, it may increase the rate of 
bone regeneration [60]. Additionally, the frozen SF/nanoHA composites showed 
increased metabolic activity compared to the non-frozen composites, a behavior that 
is most probably related to the larger pore sizes on the frozen scaffolds favouring cell 
migration. Therefore, results suggest that the composite hydrogels prepared in this 
work showed favorable cell-compatible characteristics and may be considered as an 
efficient material for cell ingrowth promotion in bone tissue engineering applications. 
 
 
5. Conclusions 
 
The aim of this study was to develop a novel composite hydrogel consisting of silk 
fibroin and nanohydroxyapatite, wherein the nanoHA particles were uniformly 
dispersed within the SF matrix. The macro/microporous structures with 
interconnected pores were successfully obtained. The compression modulus of 
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composite hydrogels increased as the nanoHA concentration increased from 10 to 15 
wt%. Considering the results from XRD and FTIR spectroscopy analysis, nanoHA and 
the silk II conformation of SF existed in the structure of the composite hydrogels. The 
incorporation of nanoHA in composite hydrogels was associated to a decrease in 
swelling properties. In addition, the incorporation of nanoHA in the SF matrix resulted 
in a composite with improved cellular metabolic activity and ALP activity. Based on the 
promising physicochemical performance of the developed composite hydrogels, 
further in vitro studies (with mesenchymal stem cells) are envisioned in order to fully 
evaluate the biological performance of the SF/nanoHA composite hydrogels. In 
conclusion, compared to the SF hydrogels the composite hydrogels with nanoHA were 
found to be more promising materials for bone tissue engineering purposes.  
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Abstract 
 
Silk fibroin (SF) is a natural, biocompatible, and biodegradable polymer having a great 
potential for the successful regeneration of damaged bone tissue. In the present 
work, nanohydroxyapatite (nanoHA) was incorporated into SF polymer to form a 
bioactive composite hydrogel for applications as bone implants. The degradation and 
bioactive properties of SF/nanoHA composite hydrogels were evaluated. Additionally, 
biological investigations of human bone marrow stromal cells (hBMSCs) viability, 
proliferation and differentiation to the osteoblastic phenotype were conducted. The 
incorporation of nanoHA in SF polymer matrices improved the bioactivity of the 
hydrogels. The biological results highlighted that the SF/nanoHA composite hydrogels 
are suitable for hBMSCs attachment and proliferation, while a test for alkaline 
phosphatase (ALP) and bone morphogenetic protein 2 (BMP-2) expression suggested 
osteoblast differentiation. Additionally, a cell staining method for ALP allowed to 
observe cell infiltration with active production of ALP by the infiltrated cells, paving 
the way to use the proposed composite hydrogel for bone tissue regeneration.  
 
Keywords: silk fibroin; nanohydroxyapatite; bioactivity; osteoblast differentiation 
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1. Introduction  
 
Scaffolds and cells are essential components in bone regenerative approaches. These 
scaffolds focus on developing biologically-based substitutes with similar structure 
and functionality to the extracellular matrix (ECM) in order to assist cell adhesion and 
proliferation. Biological scaffolds should gradually degrade to support the cell 
ingrowth and bone formation through the regeneration process, as well as to avoid 
the risk of complications that may be associated with the long-term presence of a 
foreign material [1-4]. Hydrogels have attracted extensive interest because of their 
advantageous properties similar to those of the native ECM, such as biocompatibility 
and the ability to absorb high amounts of water or biological fluids without 
dissolving, thus maintaining their three-dimensional (3D) structure and function. 
Their high permeability allows the exchange of oxygen, nutrients, and soluble 
metabolites [5-7].  
Silk fibroin (SF) is a protein polymer derived from the cocoons of Bombyx mori which 
possesses adequate properties for bone tissue engineering scaffolds, such as 
biocompatibility, biodegradability, high permeability to oxygen and water vapor, 
versatile processing, and adjustable mechanical and biochemical properties [8-11].  
SF-based composite hydrogels incorporating relevant molecules of the extracellular 
matrix such as SF/hyaluronic acid [12] and SF/collagen [13] have been reported to 
present enhanced physicochemical and biological properties for tissue engineering 
applications. In a different approach, the incorporation of a bioactive ceramic in the 
hydrogel matrix is expected to improve the osteogenic potential of the resulting 
composite. The presence of the bioactive ceramic inside a polymeric matrix would 
mimic the inorganic phase of the extracellular matrix favoring bone cell behavior and 
the interaction with the surrounding bone tissue [14, 15]. In a previous study, we 
described the preparation of novel SF-hydrogels incorporating different percentages 
of nanophased hydroxyapatite (HA) by using a new and innovative method, in which 
ethanol was used as gelling agent [8]. The SF hydrogel incorporating 15wt% of 
nanoHA, obtained by a freezing method, yielded a composite with improved 
mechanical properties together with a higher amount of uniformly dispersed 
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particles throughout the matrix, in combination with interconnected micro- and 
macroporosity suitable for new bone formation. Additionally, preliminary biological 
data performed with MG63 cells showed promising results regarding osteoblastic cell 
response [8].  
Consequently, the main goal of the current work was to exploit the suitability of the 
SF/15% wt% nanoHA hydrogel for bone regenerative strategies. For that, the 
SF/nanoHA hydrogel was prepared as described previously [8] and evaluated for 
enzymatic degradation, bioactivity and ability to promote the proliferation and 
osteoblastic differentiation of human bone marrow stromal cells.   
 
 
2. Materials and Methods 
 
2.1.  Preparation of silk fibroin solution 
Cocoons of Bombyx mori silkworm (supplied by Bratac, São Paulo, Brazil) were 
degummed in 1 g/L Na2CO3 solution at 85°C for 1 h 30 min, with Na2CO3 being 
changed every 30 min to remove the sericin of the cocoons and obtain pure SF fibers. 
Then, SF fibers were dried and dissolved in a ternary solvent of CaCl2:CH3CH2OH:H2O, 
in a molar ratio of 1:2:8, at 85 °C until total dissolution, to a SF salt solution of 10% 
(w/v). The SF salt solution was then dialyzed (cellulose membrane, Viscofan 22 EU – 
20 USA) against distilled water for 3 days, at 8 °C, with water being changed every 24 
hours. The final concentration of the SF aqueous solution was 4% (w/v), which was 
determined by weighing the remaining solid after drying. 
 
2.2. Preparation of silk fibroin/nanoHA hydrogels 
SF/nanoHA hydrogels were prepared according to our previously established method 
[8]. Briefly, the dry power of nanoHA aggregates (Fluidinova S.A., Maia, Portugal) was 
first mixed with 70% ethanol and then slowly mixed with the SF aqueous solution at 
37ºC. SF and nanoHA were mixed at ratios of SF/nanoHA 100/0 and 85/15 wt%. The 
hydrogel containing 15% of nanoHA was called SF/nanoHA15. A part of these 
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hydrogels was frozen to evaluate differences in the properties of frozen and non-
frozen hydrogels. These hydrogels were identified with the letter F.  
 
2.3. In vitro enzymatic degradation   
In vitro enzymatic degradation of the hydrogels was measured versus time, by 
incubating the gels in protease XIV solution (Streptomyces griseus, Sigma) and 
monitoring the hydrogel mass. Hydrogels sections with 7 mm diameter and 5 mm 
thickness were carefully transferred to 48-well plates and soaked in phosphate-
buffered saline solution (PBS, pH 7.4) overnight to reach swelling equilibrium. The 
gels were removed from PBS, excess liquid was blotted from the surface with filter 
paper, and the gel masses were determined. The gels were incubated at 37ºC in 1 mL 
phosphate-buffered saline solution (PBS, pH 7.4) containing the protease. The 
enzyme concentrations used in this test were 0.5 and 1.0 mg/mL [16]. The enzyme 
solution was replaced daily with freshly prepared solution. The control hydrogels 
were immersed in 1 mL PBS which was also refreshed daily. At designated time points 
(1, 3, 7 and 10 days), groups of samples were rinsed in distilled water and prepared 
for mass balance and scanning electron microscopy (SEM).  
The percentage of weight loss [W (%)] of hydrogels was determined based on the 
following equation: 
 
W (%) = (W0 – Wd)/W0 × 100 
 
where W0 is the initial weight of the hydrogel sample and Wd is the weight of the 
sample after degradation at predetermined days. 
 
2.4. Biodegradation and bioactivity assessment in SBF 
The in vitro degradation and bioactivity of the hydrogels were carried out using 
standard simulated body fluid (SBF) containing inorganic ion concentrations similar to 
those of human blood plasma [17]. The SBF solution was prepared by dissolving NaCl 
(8.035 g), NaHCO3 (0.355 g), KCl (0.225 g), K2HPO4.3H2O (0.231 g), MgCl2.6H2O (0.311 
g), CaCl2 (0.292 g) and Na2SO4 (0.072 g) into 700 mL ultrapure water. The solution 
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was buffered at physiological pH 7.4 with Tris buffer (6.118 g) and HCl. Then the total 
volume of solution was filled up to 1000 mL with ultrapure water [17]. 
Hydrogels sections with 7 mm diameter and 5 mm thickness were carefully 
transferred to 48-well plates and were soaked in ultrapure water overnight to reach 
swelling equilibrium. The gels were removed from ultrapure water, excess liquid was 
blotted from the surface with filter paper, and the gel masses were determined. 
Then, the samples were immersed separately in 20 mL SBF in closed falcon tubes at 
37 °C for 1, 3, 7, 14 and 21 days. After the different incubation time-points, the 
materials were removed from SBF solution, washed with ultrapure water and 
prepared for mass balance. Finally the hydrogels were freeze-dried, sectioned and 
viewed using SEM for apatite layer formation. 
 
2.5. SEM 
SEM was used to observe the morphology of samples after enzymatic degradation 
with protease XIV solution, as well as the apatite layer formation in the hydrogels 
after immersion in SBF.  The analysis was performed on samples sputter coated (SPI-
Module) with a thin gold/palladium film and then examined by SEM using a FEI 
Quanta 400 FEG/ESEM (FEI) scanning electron microscope at an accelerating voltage 
of 15 kV.  
 
 
 
2.6. In vitro biological studies 
 
2.6.1. hBMSCs isolation and culture 
Human Bone Marrow Stromal Cells (hBMSCs) were obtained from bone marrow 
following orthopaedic surgery procedures, with patient’s informed consent. The bone 
fragments (which would be otherwise discharged) were broken in small pieces and 
washed with alpha minimum essential medium (α-MEM, Sigma-Aldrich) 
supplemented with 10% (v/v) fetal bovine serum (FBS, Gibco), 100 IU/mL/ 2.5 µg/mL 
penicillin-streptomycin solution (Gibco) and 2.5 µg/mL amphotericin B (Gibco). The 
cell suspension was seeded in Petri dishes for 10 days. Afterwards, at 70 – 80% 
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confluence, the cell monolayer was washed with PBS twice and cells were detached 
with trypsin solution (0.04%, Gibco) and subcultured. All assays were conducted with 
cells in passage 4. 
Prior to cell seeding, the hydrogel sections with 7 mm diameter and 5 mm thickness 
were sterilized in ethanol solution at 70% (v/v) and subsequently washed twice with 
phosphate-buffered saline (PBS). For cell seeding, a suspension of 105 cells/scaffold 
was added on the top of each hydrogel. For the osteogenic medium, the above 
described medium was supplemented with 10 mM -glycerophosphate (Sigma) and 
10-8 M dexamethasone (Sigma). The seeded scaffolds were incubated in a humidified 
atmosphere of 95% air and 5% CO2 at 37 °C. All samples were cultured for 1, 7, 14 
and 21 days. The hBMSCs-seeded hydrogels were assessed for cell viability, 
proliferation, alkaline phosphatase (ALP) activity, total protein content, and F-actin 
cytoskeleton, ALP and BMP-2 immunostaining. The SF hydrogels were used as 
controls of the SF/nanoHA hydrogels.  
 
2.6.2. Metabolic activity  
At each time point, the metabolic activity was evaluated by the resazurin assay. The 
same sample was followed throughout the culture time, i.e. it was assessed at all-
time points. In the resazurin assay, a non-fluorescent blue component is reduced by 
the living cells to a pink fluorescent component. Fresh medium with 10% (v/v) of 
resazurin was added to the cells, which were incubated at 37 °C in a humidified 
atmosphere of 95% air and 5% CO2 for 3 h. Then, 100 µL were transferred to a 96-
well plate and the fluorescence intensity was measured in a microplate reader 
(Synergy HT, BioTek) at 535 nm excitation wavelength and 590 nm emission 
wavelength. The data reported were the average of measurements from three 
samples. 
 
2.6.3. DNA content 
Cell proliferation was assessed by the DNA extraction assay, at days 1, 7, 14 and 21. 
DNA content was measured using the PicoGreen DNA quantification assay (Quant-
iTTM Picogreen dsDNA assay, Molecular Probes, Invitrogen), according to the 
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manufacturer’s instructions. After washing the hydrogels with PBS, they were 
immersed in 0.5 mL of ultrapure water and placed at 37 °C /5% CO2 for 1 h, and then 
placed in a freezer at -80 °C. Subsequently, the hydrogels were thawed at room 
temperature to lyse the cell membranes. The fluorescence intensity was measured in 
a microplate reader (Synergy HT, BioTek) at 480 and 520 nm, excitation and emission, 
respectively.  
 
2.6.4. Alkaline phosphatase activity and protein content  
At each time point, colonized hydrogels were washed twice with PBS and immersed 
in 0.5 mL ultrapure water at 37 °C /5% CO2 for 1 h. They were then placed in a freezer 
at -80 °C and then thawed at room temperature to lyse the cell membranes. Alkaline 
phosphatase (ALP) activity was assayed by the hydrolysis of p-nitrophenol phosphate 
(Sigma), in alkaline buffer solution, 2-amino-2-methyl-1-propanol (Sigma), at pH 10.5. 
After 1 h of incubation at 37 °C, the reaction was stopped by adding NaOH (5M, 
Sigma), and the absorbance of the hydrolysis product (p-nitrophenol) was measured 
at 405 nm, using a plate reader (BioTek). ALP activity was normalized to total protein 
content and was expressed as nanomoles of p-nitrophenol produced per minute per 
microgram of total protein (nmol min-1/µg protein). Total protein content was 
measured by Lowry’s method with bovine serum albumin used as a standard. 
 
2.6.5. F-actin cytoskeleton, ALP and BMP-2 immunostaining  
For F-actin cytoskeleton and BMP-2 immunostaining, seeded hydrogel samples were 
fixed in 3.7% formaldehyde (Sigma) for 15 min and washed twice with PBS. Then, 
cells were permeabilized with 0.1% (v/v) Triton X-100 solution (Sigma) for 30 min. 
Afterwards, samples were washed twice in PBS and incubated in 1% bovine serum 
albumin solution in PBS (BSA, Sigma) for 30 min to avoid nonspecific binding. For F-
actin cytoskeleton immunostaining, cells were stained with Alexafluor phalloidin 488 
(Invitrogen) in 1% BSA solution for 30 min at room temperature. Samples were 
washed twice with PBS and cell nuclei were stained with a buffer of Propidium iodide 
and RNase (BD Pharmigen) for 10 min. For BMP-2 immunostaining, cells were 
incubated with the primary antibody rabbit anti-BMP2 (1:200; Abcam) overnight at 4 
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°C. Samples were then washed twice in PBS and incubated with the secondary 
antibody Alexa Fluor 488 goat anti-rabbit igG for 1h (1:1000; Molecular Probes).  
ALP staining was performed in live cells by using an Alkaline Phosphatase (AP) Live 
Stain kit (Molecular Probes, Life Technologies), according to the manufacturer’s 
instructions. Briefly, the culture medium was removed and the seeded hydrogels 
were washed twice with fresh medium. Then, and appropriate amount of 1X AP Live 
Stain solution was directly applied to the seeded hydrogels, followed by a 30 min 
incubation. Finally, the AP Live Stain was removed and the hydrogels were washed 
twice with fresh medium. 
Immunostained hydrogels were observed under a Spectral Confocal Microscope Leica 
TCS-SP5 AOBS (Leica). 
 
2.7. Statistical analysis 
The results were expressed as the average ± standard deviation. The statistical 
analysis of the results was carried out using the one-way analysis of variance 
(ANOVA) followed by post hoc Tukey HSD multiple comparison test. Levels of p < 0.05 
were considered to be statistically significant. 
 
 
3.  Results 
 
3.1.  Enzymatic degradation  
The degradation behavior of the SF and SF/nanoHA hydrogels was assessed by 
incubating the materials in protease XIV and PBS (as a control) to evaluate 
quantitative changes. Figures 1A and 1B show the weight loss of the SF and 
SF/nanoHA hydrogels, respectively, over time during a degradation period of 10 days. 
All materials presented progressive loss of mass by enzymatic hydrolysis over time. In 
contrast to SF hydrogels, which were fully degraded within 10 days, the percentage 
of weight loss of non-frozen and frozen SF/nanoHA hydrogels was 75.8% and 79.7%, 
respectively, for protease concentration of 0.5 mg/mL. Using the protease 
concentration of 1.0 mg/mL the degradation was 86.3% and 89.9% for non-frozen 
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and frozen composite hydrogels, respectively. The differences between non-frozen 
and frozen hydrogels were not significant (p>0.05) at any of the time points for both 
protease concentrations. The hydrogels incubated in PBS showed no significant 
degradation within 10 days and the structure integrity was maintained over time 
(data not shown). 
 
 
Figure 1 – Weight loss of non-frozen and frozen (A) SF and (B) SF/nanoHA hydrogels 
over time during a degradation period of 10 days by protease, and (C) SEM images of 
frozen hydrogels before degradation and after 3 and 7 days of degradation. 
 
Figure 1C shows the morphological changes of hydrogels before degradation and 
after 3 and 7 days degradation by protease XIV. Similar morphological changes were 
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observed for non-frozen and frozen hydrogels, and therefore only SEM images of 
frozen materials are shown. Before incubation, the porous structure of SF and 
SF/nanoHA hydrogels was intact and with interconnected pores (Figure 1C). After 
incubation in the enzyme solution, the morphology of both hydrogels exhibited a 
drastic change, where the hydrogels could not keep its original form and collapsed, 
completely losing the porous structure. 
 
Although a significant degradation was also observed in the composite hydrogels, an 
interesting phenomenon concerning to nanoHA distribution could not be neglected. 
As shown in Figure 2, after the degradation of the porous structure it was clearly 
visible that the nanoHA aggregates were deposited uniformly in the SF matrix.   
 
 
 
Figure 2 – NanoHA distribution in the SF/nanoHA hydrogels after the enzymatic 
degradation of the porous structure. 
 
3.2.  Apatite forming ability 
 
3.2.1. Morphology and EDS analysis 
The bioactive character of the hydrogels was tested in vitro by analyzing the ability to 
form apatite at their surface after being immersed in SBF. The prepared materials 
were immersed in SBF up to 21 days. Figure 3 shows the SEM images of apatite layer 
formation on the hydrogels after 7 and 21 days. Similar apatite formation was 
observed for non-frozen and frozen hydrogels, and therefore only SEM images of 
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frozen materials are shown. After 7 days in SBF, apatite structures had already been 
formed. After 21 days in solution, the apatite layer increased in density and was 
distributed over the entire surface of the two hydrogels.  A more marked apatite 
formation was seen on hydrogels containing nanoHA.  
The analysis of the energy dispersive spectroscopy (EDS) spectra of the frozen SF and 
SF/nanoHA hydrogels revealed the presence of the Ca and P elements, which 
corresponds to an apatite-like layer (Figure 3). The weight percentages of Ca and P 
were similar for both hydrogels at day 7. Nevertheless, at day 21, the percentage of 
these elements only slightly increased for SF hydrogels while presenting a significant 
increase for SF/nanoHA hydrogels.  
 
 
Figure 3 - SEM images and respective EDS spectra of frozen SF and SF/nanoHA 
hydrogels showing the formation of apatite after 7 and 21 days of immersion in SBF. 
The weight percentages of Ca and P are shown in the EDS spectra.   
 
3.2.2. Degradation  
Figure 4 shows the weight loss of non-frozen and frozen SF and SF/nanoHA hydrogels 
in SBF at various time intervals. The mass of non-frozen and frozen SF hydrogels did 
not significantly change over 21 days. The weight loss of non-frozen and frozen 
composite hydrogels was also not significant until day 14. However, afterwards, the 
weight loss of these composites continuously decreases so that, at day 21, the 
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samples gained weight when comparing to the initial value, before immersion in SBF, 
meaning that a deposit has been formed. This observation is in agreement with the 
results reported in the previous section, showing significant apatite formation in the 
composites, at later incubation times, compared to that observed in SF hydrogels.  
 
Figure 4 - Weight loss of non-frozen and frozen SF and SF/nanoHA hydrogels in SBF at 
various time intervals. 
 
 
3.3.  Biological studies 
 
3.3.1. Cell metabolic activity and proliferation 
Figure 5 shows the results of the metabolic activity, DNA quantification and confocal 
microscopy images for the SF and SF/nanoHA hydrogels seeded with hBMSCs, at 
different time-points.  
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Figure 5 - Cell metabolic activity and DNA content of hBMSCs cultured on non-frozen 
and frozen SF and SF/nanoHA hydrogels, and CLSM images of hBMSCs on frozen SF 
and SF/nanoHA hydrogels, for 1, 7, 14 and 21 days of culture. * indicate significant 
differences (p<0.05) between SF and SF/nanoHA hydrogels at the same culture time. # 
indicate significant differences (p<0.05) between non-frozen and frozen SF/nanoHA 
hydrogels. Data are presented as the average ± SD. hBMSCs cells were stained for F-
actin cytoskeleton with Alexafluor phalloidin (green) and nuclei with Propidium 
iodide (red). 
 
Metabolic activity increased throughout the 21 days culture time for all tested 
hydrogels. For non-frozen SF and SF/nanoHA hydrogels, no significant differences in 
metabolic activity were observed, except for a slightly increased value for the 
composite hydrogel at day 21. On the contrary, for frozen materials, a significant 
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increase in metabolic activity was observed for SF/nanoHA hydrogels at day 14 (> 
100%) and, particularly, at day 21 (~3 fold), comparatively to SF hydrogels. When 
comparing the materials of these two groups, non-frozen and frozen, no significant 
differences in metabolic activity were observed for SF hydrogels; however, the frozen 
SF/nanoHA hydrogels presented significantly increased values at days 14 and 21.  
Concerning to DNA content, the same trend of cell response was observed for SF and 
SF/nanoHA hydrogels, considering non-frozen and frozen samples.   
CLSM images of the frozen hydrogels showed that hBMSCs easily attached to the 
hydrogels and spread over the surface. At day 7, images showed cells with elongated 
morphology and cell-to-cell contact in both materials. At day 14, the cells were well 
spread out with notable cell-to-cell contact, forming an organized cell layer. At day 
21, both hydrogels were completely covered with a dense cell layer. Images also 
suggested that the SF/nanoHA hydrogels showed a denser cell layer compared to SF 
hydrogels.  
 
3.3.2. Alkaline phosphatase (ALP) activity and staining 
 ALP activity of hBMSCs cultured on non-frozen and frozen SF and SF/nanoHA 
hydrogels was analyzed at days 7, 14, and 21 (Figure 6A). ALP activity on non-frozen 
SF/nanoHA and SF hydrogels was similar during the 21 days of culture. In contrast, in 
the frozen hydrogels, at day 21, ALP activity of SF/nanoHA hydrogels was significantly 
higher than that for SF hydrogels. 
The presence of ALP was also examined in live cells, using an alkaline live stain (Figure 
6B). The ALP live stain showed that the cells were alive, functional, and 
homogeneously distributed throughout the hydrogels. On the SF hydrogel, stained 
cells were seen dispersed through the sample with irregular morphology and areas of 
higher intensity staining. Better cell response appears to occur with the SF/nanoHA 
composites. Cells presented elongated morphologies, with uniform ALP staining, cell-
to-cell contact and establishing a continuous cell layer.  
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Figure 6 – (A) ALP activity of hBMSCs on non-frozen and frozen SF and SF/nanoHA 
hydrogels for 7, 14 and 21 days of culture, and (B) fluorescence images showing 
hBMSCs stained for ALP on frozen SF and SF/nanoHA hydrogels at 21 days. * indicate 
significant differences (p<0.05) in relation to SF hydrogel at the same culture time. 
Data are presented as the average ± SD. Scale bar: 25 µm. 
 
3.3.3. BMP-2 expression 
The BMP-2 protein expression was investigated through immunostaining analysis as 
shown in Figure 7. A strong staining intensity of BMP-2 expression was observed, at 
21 days of culture, on frozen SF/nanoHA hydrogels in comparison to SF materials.  
 
 
 
Figure 7 – Fluorescence images showing BMP-2 expression in hBMSCs cultured on 
frozen SF and SF/nanoHA hydrogels at 21 days. Scale bar: 25 µm. 
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3.3.4. Cellular ingrowth inwards the porous structure  
Figure 8 presents a sequence of CLSM images showing a detail of the cell growth 
observed in the colonized frozen SF/nanoHA hydrogel inside a pore, at 21 days of 
culture. Clear evidence of cell infiltration through the pores was observed. 
Additionally, cells stained intensively for ALP through the porous structure, 
evidencing their functional activity both at the surface and within the pores walls.  
 
 
 
 
 
Figure 8 – Representative sequence of CLSM images showing the infiltration of 
hBMSCs on frozen SF/nanoHA composite hydrogel inside a pore, at 21 days of 
culture. Cells were stained with an ALP live stain (green). Scale bar: 25 µm.  
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4. Discussion 
 
The incorporation of bioactive ceramics in biodegradable polymer matrices to 
produce three-dimensional (3D) scaffold materials is an additional design feature 
needed for bone tissue engineering applications. In a previous work, a SF hydrogel 
incorporating 15% (wt%) of nanoHA with larger pore sizes, due to a freezing method, 
was developed. The micro- and macroporosity obtained combined with 
interconnective porous structure and an uniform dispersion of nanoHA particles 
throughout the fibroin matrix, makes this composite hydrogel a very promising 
alternative to be applied in bone regeneration. Therefore, the main goal of this work 
was to exploit the in vitro biological response of this SF/nano hydrogel using human 
bone marrow stromal cells. 
An appropriate degradation rate of the hydrogels is essential for bone tissue 
regeneration. It is desired that the scaffold degradation rate in vivo might match the 
rate of de novo tissue formation so that the porous structure is replaced by new 
tissue [18].  In vitro enzymatic hydrolysis provides a general idea of the 
biodegradability of a material. Generally, the enzymatic degradation of biomaterials 
is a two-step process. At first, proteolytic enzymes are adsorbed to the SF 
biomaterials, which demands that the enzymes must find binding domains on the 
material’s surface. Afterwards, SF biomaterials are enzymatically digested leading to 
the corresponding amino acids, which are easily disposed in vivo, an advantage of SF 
used in the biomedical applications [19, 20]. In the present work, while the SF 
hydrogels incubated with the protease were fully degraded within 10 days, the 
materials incubated in phosphate buffer showed no significant degradation, 
confirming that the mass loss was due solely to enzymatic hydrolysis. This marked 
degradation shows the potential of SF as a biodegradable material. Additionally, with 
the incorporation of nanoHA aggregates into the hydrogels the degradation rate was 
similar to that found in control SF materials. Furthermore, a uniform dispersion of 
nanoHA particles throughout the fibroin matrix was observed after the enzymatic 
degradation, which is crucial for a good performance of the composite hydrogel in 
bone tissue engineering. The degradation rate and the morphological structure 
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changes were similar for the non-frozen and frozen hydrogels, suggesting that pore 
size did not correlate to degradation rate. This is in agreement with previous results 
reported by Kim U. et al in SF scaffolds with different pore sizes exposed to a 
protease solution [21]. 
To be effectively used for bone tissue regeneration, it is beneficial that a material 
might promote bone-like apatite formation when in contact with physiological fluid. 
SF and SF/nanoHA hydrogels were evaluated for their bioactivity using SBF. The 
morphological analysis combined with the EDS analysis confirmed the presence of a 
CaP layer on the surface of non-frozen and frozen SF and SF/nanoHA hydrogels. 
Nevertheless, the composite hydrogel containing nanoHA had greater ability to 
induce the apatite layer formation in vitro. The nanoHA aggregates in the composite 
could act as nucleation sites and consequently the apatite could be formed more 
effectively on the composite hydrogels than on the SF hydrogels. This is in line with 
previous studies performed in chitosan-gelatin scaffolds incorporating  nanophase 
hydroxyapatite [22], also in a poly(L-lactic acid) (PLLA) matrix with the addition of HA 
particles [23]. Additionally, in the later study, the implantation of the apatite-coated 
poly(L-lactic acid)/hydroxyapatite (PLLA/HA) composite scaffold in the subchondral 
bone of healthy sheep femoral condyle yielded better integration in comparison to 
non-coated PLLA scaffolds [23]. Back to the present work, immersion of SF hydrogels 
in SBF did not result in significant weight loss during the 21 days. However, in the 
SF/nanoHA hydrogels, the weight increased from day 14 until day 21, which could be 
attributed to deposition of apatite particles (Ca2+ and PO43- ions) on the surface of the 
composite hydrogels. The present results showed an improvement of bioactivity on 
the composite hydrogels indicating that these materials have great potential for bone 
tissue engineering. 
Hydrogels for bone regeneration must be cytocompatible and actively encourage 
ingrowth of cells. As evaluated by the resazurin assay and DNA quantification, the 
increase of metabolic activity and proliferation, respectively, of hBMSCs on hydrogels 
over time indicated the cytocompatible of these materials. These results correlated 
well with confocal images that showed extensive cell spreading and proliferation 
within the hydrogels. For later culture times, the hBMSCs cultured in the hydrogels 
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with nanoHA proliferated significantly, showing an inductive effect of the presence of 
nanoHA. Previous studies had also proven that the inclusion of nanoHA in scaffolds of 
pullulan and dextran could enhance the proliferation of hBMSCs in the hydrogels 
[24]. Moreover, this tendency was particularly confirmed in the case of frozen 
SF/nanoHA hydrogels, showing that the increase of pore size of frozen materials [8] 
may play a prominent role in metabolic cell activities and proliferation. Bhardwaj N et 
al also reported that the metabolic activity and proliferation ability of the cells was 
higher in SF/chitosan scaffolds with larger pores [25].  
One of the most attractive characters that hBMSCs show is their multiple 
differentiation potential. Under appropriate conditions, hBMSCs are able to 
differentiate towards several cell lineages, including osteoblasts, adipocytes 
chondrocytes, and myocytes. Differentiation is induced through addition of 
“cocktails” of morphogens and chemicals inducing the differentiation of a particular 
cell type. In vitro, differentiation is verified by demonstrating the induction of specific 
gene expression and proteins [26-28]. In osteogenesis, differentiation of hBMSCs into 
osteoblasts is a key step and ALP is an important early marker for cells undergoing 
differentiation to form osteoblast [29]. ALP activity, normalized as a function of the 
protein content, was the highest in the case of frozen SF/nanoHA composite 
hydrogels at 21 days of culture, showing the efficacy of nanoHA aggregates in 
enhancing the osteoblastic phenotype expression level. Furthermore, it is worth 
noting that this difference in ALP expression between frozen SF and SF/nanoHA 
materials was observed in a quantitative assay and also in a live cell staining. Several 
other works can be found in the literature indicating the effect of nanoHA in the ALP 
expression in different composite materials, such as poly(L/DL)-lactide/nanoHA 
membranes [30], nanoHA/polyamide scaffolds [31], and poly(L-lactic acid)/poly-
benzyl-L-glutamate/collagen/nanoHA scaffolds [32]. 
Immunofluorescent staining of BMP-2 protein showed greater expression in the 
SF/nanoHA composite hydrogels compared to that of control SF materials. Bone 
morphogenetic proteins (BMPs) play an important role in osteoblast differentiation 
and deposition of bone matrix. The high osteoinductive potential of some BMPs is 
illustrated by their ability to induce bone formation. Among them, BMP-2 protein is 
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essential to induce the expression of Runt-related transcription factor 2 (Runx-2) and 
Osterix, the two critical transcription factors in osteoblast differentiation. Runx-2 is 
the main regulator for the expression of downstream key genes, as collagen type I, 
alkaline phosphatase, osteopontin, bone sialoprotein and osteocalcin, at an early 
stage of osteoblastic differentiation. Runx-2 has also a role in the regulation of the 
Osterix expression, a later key transcription factor for osteoblastic differentiation, 
which is involved in collagen type I and osteocalcin gene activation, being also a 
downstream regulator for Runx-2 activity [33-36].  
Hydrogels should have the ability to regenerate functional bone tissue at the site of 
injury through a cell migration process in a carefully orchestrated manner. Initial 
attachment of cells is especially critical for long-term cells stability and 
differentiation.  The ability of the composite hydrogel to support hBMSCs adhesion 
and proliferation was also evaluated using a live cell fluorescence staining for ALP. 
CLSM images showed that hBMSCs were able to infiltrate and migrate within the 
hydrogel, through the porous structure. Furthermore, one interesting finding in this 
work was that ALP expression in hBMSCs was observed within the SF/nanoHA 
hydrogel, indicating not only cell infiltration into the material, but also active 
production of ALP by the infiltrated cells.  
The results of the current work support the potential of this composite hydrogel as a 
material for stimulating new bone tissue formation.   
 
 
5. Conclusions 
 
Advances in bone tissue engineering require biofunctional hydrogels that interact 
with bone forming cells. To achieve this goal, a SF/nanoHA composite hydrogel with 
improved bioactivity was developed. The SF/nanoHA hydrogels can act as matrix for 
hBMSCs viability and proliferation, which was significantly improved on frozen 
composite materials. Confocal images showed that hBMSCs could spread and 
proliferate on these hydrogels during 21 days of culture. Furthermore, an 
improvement of the osteogenic response, as seen by ALP and BMP-2 expression, was 
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observed for composite materials. Also, evident infiltration of functionally active cells 
through the porous hydrogel structure was noticed. This work therefore enlightens to 
the development of new bone implantable scaffolds potentially useful in 
regenerative medicine.  
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Abstract 
 
The rapid emergence of antibiotic resistance is becoming an imminent problem in 
bone tissue engineering, and therefore biomaterials must be modified to promote the 
tissue integration before bacterial adhesion. In this work, silk 
fibroin/nanohydroxyapatite hydrogel was modified with in situ synthesized silver and 
gold nanoparticles (AgNPs and AuNPs), taking advantage of the tyrosine amino acid. 
The presence of AgNPs and AuNPs in the hydrogels was characterized by UV 
spectrophotometer, transmission electron microscopy and thermogravimetric analysis. 
In vitro antimicrobial studies revealed that hydrogels with AgNPs and AuNPs exhibited 
significant inhibition ability against both Gram-positive and Gram-negative bacteria. 
Cytocompatibility studies carried out using osteoblastic cells revealed that up to 0.5 
wt% of AgNPs, and for all concentrations of AuNPs, the hydrogels can be effectively 
used as antimicrobial materials, without compromising cell behavior. On the basis of 
the aforementioned observations, these hydrogels are very attractive for bone tissue 
engineering. 
 
Keywords: Silk fibroin; nanohydroxyapatite; silver nanoparticles; gold nanoparticles; 
antimicrobial activity 
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1.  Background 
 
The ideal approach for bone tissue engineering is that the tissue integration occurs 
prior to bacterial adhesion, thereby preventing material colonization for certain 
bacterial species. Adhesion of bacteria to human tissue and implanted biomaterials is 
the first critical step in the pathogenesis of infection, whereby the bacteria can divide 
and colonize the surface. After adhering to the surface, some bacterial strains, 
particularly Staphylococcus epidermidis, secrete a layer of slime, which serve to anchor 
the bacterial cells. Bacterial biofilms are particularly problematic because sessile 
bacteria can often withstand host immune response and antibiotic therapies. 
Additionally, these sessile biofilms can give rise to nonsessile individuals, planktonic 
bacteria that can rapidly multiply and disperse. 1-4 A very large proportion of 
biomaterial-associated infections in orthopedics are caused by S. aureus and S. 
epidermidis, the main responsible agents for the two major types of infection affecting 
bone, septic arthritis and osteomyelitis, with consequent devastating effects on bone 
and surrounding soft tissues. Treatment for S. aureus infections is often complex, 
namely due to the emergence of methicillin-resistant S. aureus (MRSA) strains and 
resistance to other classes of antibiotics. 1, 5 
The increase in antibiotic-resistant bacterial strains has prompted a renewed interest 
in the development of new antimicrobial approaches. 6-8 Metallic elements have 
garnered prominent consideration as they present antimicrobial properties. Moreover, 
these metallic elements in the form of nanoparticles are excellent candidates for 
antimicrobial applications due to their large surface area to volume ratio, providing 
better contact with microorganisms, and these nanoparticles are also an encouraging 
approach concerning their chemical stability, long life, and heat resistance. 9, 10 In 
recent years, silver nanoparticles (AgNPs) have attracted much attention for a range of 
biomedical applications owing to their potent antimicrobial activity against a large 
number of bacteria, including antibiotic-resistant strains. 11-13 The antibacterial activity 
of AgNPs has been related to inhibition of enzymatic activities, prevention of DNA 
replication and disruption of bacterial cell membranes. 9, 14 Gold nanoparticles (AuNPs) 
are also getting huge attention since their antimicrobial activity has been recently 
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reported. 15, 16 The exact mechanism of bacterial growth inhibition have not been 
elucidated yet, however some reports present the bacterial wall damage as the cause 
of the bacterial cell death. 17 
Silk fibroin (SF) is a natural, biocompatible, biodegradable and low-cost polymer 
obtained from the cocoons of Bombyx mori with 5263 amino acids residues composed 
of glycine, alanine, serine, tyrosine, valine, and only 4.7% of the other 15 amino acid 
types. 18, 19 The tyrosine residues in SF has strong electron donating properties making 
this polymer an appealing template for Ag and Au nanoparticles biosynthesis as both 
reducing and stabilizing agents. 20  
In a previous work, the incorporation of nanosized HA particles (nanoHA) into porous 
SF hydrogels showed promising physicochemical performance with improved 
osteoblastic induction characteristics. 21 Thus, the results of this previous work 
supported the potential application of this composite as a bone graft substitute for 
clinical situations when local bone formation is needed. Therefore, providing 
antimicrobial properties to this composite with nanoHA could greatly improve the 
current bone tissue engineering strategies. In this context, our work was designated to 
produce a hydrogel containing SF and nanoHA for bone tissue engineering with 
antimicrobial properties by forming silver or gold nanoparticles in situ, an approach 
that has been poorly explored.   
 
 
2.  Methods 
 
2.1.  Preparation of silk fibroin solution 
Cocoons of Bombyx mori silkworm (supplied by Bratac, São Paulo, Brazil) were 
degummed in 1 g/L of Na2CO3 solution at 85 °C for 1 h 30 min, with Na2CO3 changes 
every 30 min, to remove the sericin of the cocoons and obtain pure SF fibers. Then, SF 
fibers were dried and dissolved in a ternary solvent of CaCl2:CH3CH2OH:H2O, at 85 °C 
until total dissolution, to a SF salt solution of 10% (w/v). The SF salt solution was then 
dialyzed (cellulose membrane, Viscofan 22 EU – 20) against distilled water for 3 days, 
with water changes every 24 hours.  
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2.2. In situ synthesis of AgNPs and AuNPs in the SF/nanoHA hydrogels 
The synthesis of silver nanoparticles was realized by simply mixing different 
concentrations of silver nitrate (AgNO3, Sigma) with SF solution, in order to prepare 
four types of hydrogels with AgNPs concentrations of 0, 0.1, 0.5 and 1%. Afterwards 
the SF/nanoHA hydrogels were prepared according to our previously established 
method. 21 Briefly, the dry power of nanoHA aggregates (Fluidinova S.A., Maia, 
Portugal) was first mixed with 70% ethanol and then slowly mixed with the SF aqueous 
solution at 37 °C. After forming the hydrogels at 37 °C the reaction process to produce 
the AgNPs was carried out by exposure the materials to the light at room temperature.  
Gold nanoparticles were also obtained by reducing gold ions in SF solution. Different 
concentrations of gold (III) chloride trihydrate (HAuCl4.3H2O, Sigma) were first mixed 
with the solution of nanoHA in ethanol. Then, these solutions were slowly mixed with 
the SF solution to achieve hydrogels with AuNPs concentrations of 0, 0.1, 0.5 and 1%, 
and the hydrogels were prepared at 37 °C. After, the AuNPs formation into the 
hydrogels was carried out at 60 °C.  
The obtained hydrogels with AgNPs and AuNPs were then frozen at -20 °C for 24 h. 
Afterwards the hydrogels were thawed and immersed in distilled water, which was 
replaced at regular intervals over a period of 24 h, to remove unreacted AgNO3 and 
HAuCl4.3H2O from the hydrogel network.  
 
2.3. Formation of AgNPs and AuNPs in the hydrogels 
The hydrogels were cut into pieces and 5 mg of each hydrogel were immersed in 
protease XIV solution (1 mg/mL) (Streptomyces griseus, Sigma) at room temperature 
over a period of a week to obtain the AgNPs and AuNPs release solutions. UV-visible 
spectral measurements of SF/nanoHA hydrogels with silver and gold nanoparticles 
were performed using a Shimadzu UV-2550 UV-Vis spectrophotometer at room 
temperature in the wavelength range from 300 to 800 nm. The morphology and size of 
AgNPs and AuNPs were evaluated by transmission electron microscopy (TEM) using a 
TECNAI G2 20 TWIN microscope at 75 kV, and the samples were prepared by placing a 
drop of colloidal dispersion on a carbon-coated copper grid, followed by solvent 
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evaporation at room temperature. The average particle sizes of AgNPs and AuNPs 
were measured using ImageJ software to analyze the TEM images. The presence of 
elemental silver and gold was determined by using EDX Zeiss Evo equipped on the 
TEM. Thermogravimetric analysis (TGA) was performed using a TA instruments Q500 
device. The samples were heated from room temperature to 800 °C with a heating rate 
of 10 °C/min under nitrogen atmosphere. Afterwards, nitrogen was replaced by air 
treatment at 800 °C to calculate the inorganic residue content.   
 
2.4. Mechanical properties of hydrogels 
To evaluate the rheological properties, the hydrogels were allowed to swell in distilled 
water for 48 h to reach equilibrium swelling. Rheological measurements were 
performed in a Haake RSI rheometer under controlled temperature at 37 °C using 
parallel plates of 20 mm diameter. Once the range of linear viscoelastic response was 
determined, rheological properties were studied in oscillatory experiments in the 
frequency range of 0.01-1 Hz. The storage and loss moduli, G’ and G’’, respectively, 
were determined as functions of the frequency. 
 
2.5. Antimicrobial activity of hydrogels with AgNPs and AuNPs 
 
2.5.1. Bacterial strains and culture conditions 
S. aureus (ATCC 25923, MSSA), S. aureus (ATCC 33591, MRSA), S. epidermidis RP62A 
(ATCC 35984), E. coli (ATCC 25922), and P. aeruginosa (ATCC 27853) were used in all 
experiments. The cultures were grown on Tryptic Soy Broth (TSB) broth (Liofilchem) 
over 24 h at 37 °C. The bacterial suspensions were prepared and adjusted to cell 
density of approximately 108 cells/mL in TSB at an optical density of 640 nm. The 
bacterial suspension (1 mL) was inoculated onto the hydrogels, previously sterilized in 
70% ethanol (v/v), and placed in 48-well plates. After incubation at 37 °C during 24 h, 
the antibacterial activity was evaluated for sessile and planktonic bacteria. Hydrogels 
without NPs were used as control.  
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2.5.2. Planktonic bacteria assessment 
After 24 h of incubation, 100 µL of supernatant were transferred to 96-well plates and 
the bacterial density was measured in a microplate reader (Synergy HT, BioTek) at 640 
nm. Results were expressed as percentage of the control. 
 
2.5.3. Metabolic activity of sessile bacteria 
The metabolic activity of sessile bacteria was evaluated by resazurin assay. After 24 h 
of incubation at 37 °C the bacterial suspension was removed and the samples were 
carefully rinsed twice with 0.9% NaCl solution in order to remove loosely attached 
bacteria. Hydrogels were transferred to 48-well plates and fresh TSB containing 10% of 
resazurin was added to each well and subsequently the plates were incubated for 3 h 
at 37 °C. Afterwards, 100 µl were transferred to a 96-well plate and the fluoresce 
intensity was measured in a microplate reader (Synergy HT, BioTek) at 530 nm 
excitation wavelength and 590 nm emission wavelength. Results were expressed as 
percentage of the control. 
 
2.6. In vitro cytocompatibility studies 
 
2.6.1. Cell culture 
Hydrogel sections with 7 mm diameter and 5 mm thickness were sterilized in 70% 
ethanol (v/v). Hydrogels without AgNPs and AuNPs were used as controls. Osteoblast-
like cells (MG63 cell line) were seeded on the top of the hydrogels at a density of 1×105 
cells/scaffold in minimum essential medium (MEM) Eagle, alpha modification (a-MEM) 
supplemented with 10% fetal bovine serum, 100 IU/mL penicillin, 2.5 µg/mL 
streptomycin, (Gibco) and 2.5 µg/mL amphotericin B (Gibco). The cultures were 
incubated at 37 °C in a humidified atmosphere of 95% air and 5% carbon dioxide (CO2).  
 
2.6.2. Resazurin assay  
After 1, 4 and 7 days of incubation, the metabolic activity was evaluated using the 
resazurin assay. The same sample was followed throughout the culture time, i.e. it was 
assessed at all time-points. Briefly, after each culture time point, fresh medium with 
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10% (v/v) of resazurin was added to each well and the plates were incubated for 3 h at 
37 °C. Subsequently, 100 µl were transferred to a 96-well plate and the fluorescence 
intensity was measured in a microplate reader (Synergy HT, BioTek) at 535 nm 
excitation wavelength and 590 nm emission wavelength. Results were expressed as 
percentage of the control (materials without nanoparticles). 
 
2.6.3. Confocal laser scanning microscopy 
Cells were fixed in 3.7% formaldehyde (Sigma) for 15 min and then washed twice in 
PBS. Afterwards, the cell-seeded surfaces were incubated for 30 min with 0.1% (v/v) 
Triton X-100 solution (Sigma) and 30 min with 1% bovine serum albumin solution in 
PBS (BSA, Sigma). Cell cytoskeleton filamentous actin (F-actin) were stained with 
alexafluor phalloidin 488 (Invitrogen) in 1% BSA solution for 30 min at room 
temperature. Samples were washed twice with PBS and cell nuclei were stained with a 
buffer of Propidium iodide and RNase (BD Pharmigen) for 10 min. Then, the materials 
were washed twice with PBS and the cell morphology was evaluated with a Spectral 
Confocal Microscope Leica TCS-SP5 AOBS (Leica). 
 
2.7. Statistical analysis 
The results were expressed as the average ± standard deviation. The statistical analysis 
of the results was done using the one-way analysis of variance (One-way ANOVA) 
followed by post hoc Tukey HSD multiple comparison test. Levels of p < 0.01 were 
considered to be statistically significant. 
 
 
3. Results  
 
3.1. In situ synthesis of AgNPs and AuNPs in SF/nanoHA hydrogels 
Different compositions of Ag and Au nanoparticles were incorporated into the 
SF/nanoHA hydrogels as shown in Figure 1.  
The SF/nanoHA hydrogels containing silver nitrate, after exposed to the light at room 
temperature, gradually changed to yellow, indicating the formation of AgNPs (Figure 
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1). Moreover, the shade of yellow was dependent on silver nitrate concentration, 
being darker with increasing silver concentration. 
The formation of AuNPs at room temperature was not possible. The reduction of gold 
ions only occurred when the temperature was raised to 60ºC. In this case the 
hydrogels containing gold (III) chloride trihydrate gradually changed to violet, 
indicating the formation of AuNPs. As in the previous case, the color intensity was 
dependent on gold concentration, being more intense for higher concentrations. 
It is worth noting that no color change was observed in the SF/nanoHA hydrogels 
without AgNO3 or HAuCl4.3H2O, which were kept under the same conditions as the 
other respective samples.  
 
 
Figure 1 - Photographs illustrating SF/nanoHA hydrogels with different AgNPs and 
AuNPs concentrations over different periods of time. 
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3.2. UV–visible spectroscopy 
Figure 2 shows the UV-vis spectra recorded from the beginning of the reaction till 30 h 
later for SF/nanoHA hydrogels with silver and gold nanoparticles. The SF/nanoHA 
hydrogel was used as control and absorption bands in the range 300-800 nm were not 
observed. After 8 h a new adsorption bands started to appear at around 400 nm and 
525 nm for AgNPs and AuNPs, respectively. These bands increased as the reaction 
proceeded, reaching a maximum at 24 h. Afterwards, the intensity of the band did not 
change and the reaction was considered completed. 
 
 
Figure 2 - UV-Vis adsorption spectra of SF/nanoHA hydrogels containing 1% of AgNPs 
and 1% of AuNPs synthesized in situ over different periods of time. 
 
3.3. TEM analysis 
The presence of AgNPs and AuNPs was also analyzed by TEM (Figure 3). The TEM 
images showed that both AgNPs and AuNPs were mainly spherical in shape and 
uniformly distributed in the hydrogel matrix without aggregation. The resulting 
average particle size with standard deviations of the silver and gold nanoparticles was 
determined by measuring 50 nanoparticles. The hydrogels with higher concentration 
of AgNPs and AuNPs presented larger nanoparticles, with a size distribution ranging 
from 12.7 to 69.1 nm and 9.3 to 54.7 nm, respectively. 
The elemental analysis of the AgNPs and AuNPs was performed using the energy 
dispersive X-ray analysis (EDX). The EDX spectra showed strong signals corresponding 
to silver and gold, confirming the presence of these NPs (Figure 3).   
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Figure 3 - TEM images with different concentrations of AgNPs and AuNPs and their 
respective EDX spectra showing the characteristic peaks. 
 
3.4. Rheological measurements 
The rheological behavior of the 7 different gels was investigated by measuring the 
elastic (G′) and viscous (G′′) moduli as a function of frequency at 37 °C (Figure 4). In all 
cases, G′ was greater than G′′ in the entire frequency range. Indeed, the G’ values for 
all hydrogels were above 1000 Pa, while the G’’ values were below 500 Pa, over the full 
frequency range evaluated. It is evident from Figure 4 that the in situ reduction of 
silver nitrate and gold (III) chloride trihydrate within the hydrogel matrices, to form 
AgNPs and AuNPs respectively, enhanced the hydrogels mechanical stiffness, as 
illustrated by the increase  in G’ values as a function of NPs concentration. 
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Figure 4 - Storage modulus (G′ - solid symbols) and loss modulus (G′′ - open symbols) as 
a function of frequency, for SF/nanoHA hydrogels with different concentrations of 
AgNPs (A) and AuNPs (B). 
 
3.5. Antimicrobial activity of SF/nanoHA hydrogels with AgNPs and AuNPs 
The antimicrobial activity of the synthetized silver and gold nanoparticles against 
sessile and planktonic bacteria in the medium was investigated against both gram-
positive (MSSA, MRSA, S. epidermidis) and gram-negative (E. coli, P. aeruginosa) 
bacteria.  
The results of metabolically active bacteria attached on hydrogels showed that the 
hydrogels containing the two highest concentrations of AgNPs exhibited a strong and 
significant reduction in the sessile bacteria for both gram-positive and gram-negative 
as shown in Figure 5.  
The results concerning to AuNPs were not so linear. Hydrogels with AuNPs didn’t show 
antimicrobial activity toward S. epidermidis. Noteworthy, the materials having AuNPs ≥ 
0.5% presented antimicrobial activity toward MRSA and P. aeruginosa, and hydrogels 
having ≥ 0.1% showed antimicrobial effect against MSSA and E. coli.  
Similar trends in antimicrobial activity were also obtained with planktonic bacteria as it 
can be seen in Figure 5. 
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Figure 5 - Sessile and planktonic growth of MSSA, MRSA, S. epidermidis, E. coli and P. 
aeruginosa on SF/nanoHA hydrogels containing different AgNPs and AuNPs 
concentrations, as percentage of the control materials without nanoparticles, after 24 
h of incubation. *p < 0.01, significant reduction compared to hydrogels without NPs. 
 
3.6. Cytocompatibility studies 
The in vitro cytocompatibility of hydrogels with AgNPs and AuNPs was investigated 
using resazurin assay on osteoblast cells and the data are presented in Figure 6. The 
cells were seeded to different concentrations of AgNPs and AuNPs for 1, 4 and 7 days. 
For the materials with silver nanoparticles a concentration-dependent decrease in cell 
viability was observed. An initial inhibitory effect followed by cell recovery was 
observed for the hydrogels with AgNPs at concentrations of 0.1 and 0.5%. However, on 
the hydrogels with 1% of AgNPs the cellular viability was lower than the control 
samples, presenting a cell viability of around 30% at day 7. As can be seen in Figure 6, 
hydrogels with AuNPs shows no toxic effects at all nanoparticles concentration. 
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Figure 6 - Influence of different AgNPs and AuNPs concentrations on osteoblast-like 
cells viability, as a percentage of cells on materials without AgNPs and AuNPs, 
respectively, after 1, 4 and 7 days of culture. *p < 0.01, significant reduction compared 
to hydrogels without AgNPs for the same culture time. 
 
To monitor the effects of the nanoparticles on the distribution and morphology of the 
cells cultured on the materials confocal characterization was carried out (Figure 7). 
Confocal images showed that the hydrogels with AgNPs, at concentrations up to 0.5%, 
and the materials with AuNPs, allowed the attachment and spreading of the osteoblast 
cells, with an elongated morphology and cell-to-cell contacts, similar to the respective 
controls. On hydrogels with 1% of AgNPs, few cells were visible at day 7. 
 
Figure 7 - CLSM images of osteoblastic cells at day 7 on SF/nanoHA hydrogels with 
different concentrations of AgNPs and AuNPs. MG63 cells were stained for F-actin 
cytoskeleton with alexafluor phalloidin (green) and nuclei with Propidium iodide (red). 
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4. Discussion  
 
The best conditions to promote the gelling of SF in the presence of nanoHA were 
previously studied. 21 Briefly, 4 wt% of SF aqueous solution was mixed with nanoHA 
previously dissolved in 70% ethanol solution and the hydrogels were prepared at 37ºC 
for 15 min. In order to prepare well-distributed silver and gold nanoparticles 
containing SF/nanoHA hydrogels, we relied on the redox ability of one of the amino 
acids presented in the SF structure, the tyrosine, to prepare AgNPs and AuNPs in situ. 
Chen group demonstrated the capability of SF to reduce Ag+ to Ag to prepare silk-silver 
nanoparticles under the presence of light. 22 Following this approach SF/nanoHA 
hydrogels with silver and gold nanoparticles were prepared.  The gels were placed 
under light and temperature in the case of silver and gold, respectively, to form the 
AgNPs or AuNPs containing hydrogels. 
The first optical indication of AgNPs and AuNPs formation was given by the color 
change of the SF/nanoHA hydrogels from colorless to yellow and to violet, 
respectively. The reduction of silver and gold ions into nanoparticles was then 
confirmed by UV-Visible spectra as a function of time with absorbance bands around 
400 nm and 525 nm reported to be specific for AgNPs 23, 24 and AuNPs 17, 25, 
respectively. Moreover, the adsorption bands observed around 400 nm and 525 nm 
suggests the formation of spherical silver 24, 26 and gold 17, 27 nanoparticles, 
respectively. These results obtained from UV spectra showed good agreement with the 
data obtained by TEM images that showed the presence of spherical AgNPs and AuNPs 
with a homogeneous dispersion, confirming a high stabilizing potential of fibroin. 
Furthermore, both the number and size of these NPs increased when the 
concentration of silver nitrate and gold (III) chloride trihydrate increased. Previous 
studies also reported this relationship between the silver and gold contents and the 
nanoparticles size. 28, 29 Based on these results of photographs, UV-Vis spectroscopy, 
TEM and TGA it is obvious that fibroin was the main responsible for the formation of 
Ag and Au nanoparticles. 
Rheological measurements showed that for all hydrogels G′ was greater than G′′ in the 
entire frequency range, neither moduli showing any significant frequency dependence 
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at low frequencies, which confirmed the gel behaviour. Moreover, as expected well 
distributed inorganic NPs improved the stiffness of the hydrogels. 30   
New developments for bone tissue engineering should target solutions that cover the 
most relevant bacterial strains involved in implant-associated infections such as MRSA, 
that represent the increasing problem of multi-drug resistant infections, and S. 
epidermidis and P. aeruginosa, that are well-described strong biofilm producers. 31-33 
Hydrogels with AgNPs at concentrations ≥ 0.5% presented a clear dose-dependent 
antimicrobial activity against all bacteria, including MRSA, S. epidermidis and P. 
aeruginosa. A similar effect to the antimicrobial activity of AgNPs in a concentration 
dependent manner has been stated. 10, 34, 35 There is significant discussion on the mode 
of antimicrobial activity of AgNPs, and both contact killing and/or ion mediated killing 
have been proposed. The mechanism of silver ions release was showed by Xiu Z et al. 
where the toxicity of the silver nanoparticles was explained by the presence of 
released Ag+. 36 However, it has been reported that the antimicrobial activity of AgNPs 
cannot be attributed solely to the released Ag+ ions but also to the nanoparticle itself. 
37, 38 The silver nanoparticles have the ability to attach to the bacterial cell membrane, 
and also penetrate inside the bacteria causing damage by interacting with 
phosphorous- and sulfur- containing compounds like DNA. 9 The nanoparticles 
preferably attack the respiratory chain, cell division finally leading to cell death. 9 An 
antimicrobial ability of AuNPs was also noticed against MSSA, MRSA, E. coli and P. 
aeruginosa but not toward S. epidermidis. However, the antimicrobial activity against 
P. aeruginosa was not so active compared to the other bacteria. Also, the hydrogels 
with 0.5% of AgNPs were not so effective against both S. epidermidis and P. 
aeruginosa. This can be related to the ability of these particular strains to colonize the 
surface, followed by slime production, and to form a biofilm that allows this bacteria to 
exhibit increased protection. 33, 39 Interestingly, the materials with AuNPs were able to 
inhibit the bacterial adhesion in lower concentrations than AgNPs. However, the % of 
inhibition at concentrations of 0.5 and 1% was higher for the hydrogels with AgNPs. 
Ahmad T. et al also showed that AgNPs exhibited higher antimicrobial action as 
compared to the AuNPs against both S. aureus and E. coli. 40 This observation may be 
due to the higher surface activity of the AgNPs as compared to the AuNPs. 40 The 
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antimicrobial effect of AgNPs and AuNPs was also reflected in the planktonic bacterial 
cells, similarly to sessile bacteria, which is crucial to prevent post-surgery infection 
leading to normal healing and osseointegration. 
Since antimicrobial materials need to combine antimicrobial activity to fight bacterial 
infections without compromising cell viability, cytotoxicity assays were carried out with 
an osteoblast-like cell line. Concerning to materials with AgNPs, increasing the 
concentration from 0.5% up to 1%, the most cytotoxic effect was observed, where cell 
viability reduction reached almost a 30%, suggesting that silver nanoparticles beyond 
0.5% concentration may be toxic. Sumitha MS et al. also showed a toxic effect of 
AgNPs to cells at higher concentrations. 41 Likewise, Agarwal A et al. reported that high 
loadings of silver nanoparticles were found to be toxic to a murine fibroblast cell line. 
42 Reversely, the hydrogels with AuNPs showed no toxic effects even at higher 
nanoparticles concentration presenting outstanding cell viability. The microscopic 
observations supported the resazurin results, showing a remarkable reduction of cell 
number for the materials with 1% of AgNPs. On the contrary, the osteoblastic cells, 
cultured on hydrogels with AgNPs up to 0.5% and on materials with AuNPs, displayed 
their typical structure with an organized actin network and elongated morphology. 
Overall, the hydrogels containing 0.5% of AgNPs presented strong antimicrobial 
activity, both anti-sessile and anti-planktonic bacteria properties, reducing the bacteria 
attachment and further accumulation. These materials simultaneously allowed the 
adhesion and spreading of osteoblastic cells. The hydrogels with AuNPs also showed 
antimicrobial activity and no toxicity against osteoblastic cells. 
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Supplementary Material 
 
TGA data 
 
The thermogravimetric behavior of the SF/nanoHA hydrogels with AgNPs and AuNPs 
was analyzed with TGA (Figure S1). All the curves showed two degradation steps, the 
first started from around 100ºC, indicating the evaporation of adsorbed water, and the 
second step, which started to decline sharply at around 300ºC, was due to the thermal 
degradation of silk fibroin protein. 21 Moreover, the TGA data showed that the 
materials, with and without nanoparticles, presented a similar pattern in their curves, 
indicating no significant differences in their thermal stability. With the incorporation of 
AgNPs and AuNPs the residual weight increased slightly compared to hydrogels 
without NPs, confirming the in situ synthesis of these nanoparticles. 
 
Figure S1 - TGA curves of SF/nanoHA hydrogels without and with AgNPs and AuNPs. 
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There is a substantial unmet demand for materials to repair injured, degenerated or 
congenitally defected bone tissues. Bone tissue engineering has been proposing 
solutions to address these clinical problems. Successful strategies in most cases require 
3-dimensional scaffolds with controllable structural, morphological and degradation 
features matched to the targeted clinical application. The use of natural polymers as 
scaffolds in bone tissue engineering has been gaining widespread attention owing to 
their significant similarities with the extracellular matrix (ECM), biocompatibility, 
biodegradability, chemical versatility, low cost and ease of processing [1, 2]. The 
interplay of factors such as concentration of polymer used in processing, structural 
stability, pore size, tissue ingrowth, and degradation are keys to the understanding of 
the scaffold behavior. Among naturally derived polymers, silk fibroin, a natural fibrous 
protein, meets most of the requirements for a biomaterial, including excellent 
processability, biocompatibility, controlled degradation rate, high oxygen and water 
vapor permeability, the presence of easily accessible chemical groups for functional 
modifications, low cost, and material format versatility [3, 4]. The utility of silk fibroin 
as a biomaterial has evolved tremendously over the years to include an impressive 
portfolio of applications (drug delivery vehicles, implants, tissue scaffolds), which are 
continuously expanding [3, 5]. Due to the above mentioned reasons, recent advances 
have greatly expanded the processing windows for three-dimensional SF porous 
hydrogels [6-10]. In the context of creating more effective bioactive hydrogels, 
applying bioceramics is one of the best-known methods to improve bone repairing [11, 
12]. As a biocompatible, bioactive and osteoconductive material, nanoHA is one of the 
most widely used calcium phosphate ceramics due to its chemical similarities to the 
inorganic component of natural bone tissue [13].  
The main goal of the present work was to evaluate the effect of nanoHA incorporation 
into SF hydrogels on physiochemical and biological behavior. Therefore, novel SF based 
hydrogels incorporating different percentages of nanophased hydroxyapatite 
(nanoHA), by using a new and innovative method, were developed through non-
freezing and freezing methodologies. These composite hydrogels involving a 
biodegradable SF polymer and a bioactive nanoHA ceramic can offer the desired 
properties for bone tissue ingrowth, such as appropriate porosity, adequate 
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mechanical properties, bioactivity and osteoconductivity, improving their biological 
properties.  
Three-dimensional and interconnected porous hydrogels of SF incorporated with 
nanoHA, in combination with large pore sizes for bone tissue engineering, were 
obtained by the freezing method, exhibiting both microporosity and macroporosity 
structure. This 3D architectural parameters of the hydrogel (porous structure, pore 
size, and interconnectivity) are believed to contribute significantly to the development 
of biological functions in tissue [14], being crucial to provide adequate space for cell 
attachment and proliferation, cell-matrix interactions, diffusion of nutrients and 
metabolites, and vascularization to the developing bone tissue. While large pores allow 
effective nutrient supply, gas diffusion, and metabolic waste removal, small pores are 
essential for the cell attachment and intracellular signaling. Consequently, the 
conception of hydrogels containing both micro- and macroporosity may provide the 
essential physical support for cellular growth [15-17].  
The ability of the hydrogels to take up fluids from the surrounding medium also plays 
an important role in tissue engineering. The water swelling of hydrogels occurred 
rapidly, and the materials were capable to hold the amount of water uptake in its 
network structure, showing that the hydrogels possess good hydration ability while 
maintaining their structural integrity. The incorporation of nanoHA in the polymeric 
matrix decreased the swelling capability of composite hydrogels, perhaps due to the 
lower water uptake ability of this ceramic, when compared to SF protein, which is 
consistent with previous studies [18, 19]. For example, Thein-Han W et al also reported 
a decrease in the swelling degree due to addition of nanoHA aggregates to chitosan 
scaffolds [19]. Furthermore, the frozen materials presented higher swelling capacity, 
which can be attributed to the different porosities of the hydrogels. This trend is in 
agreement with previously reported observations [20]. Swelling and porosity aid in the 
supply of nutrients to the interior of the 3D materials and also increase the surface 
area for cell proliferation. Thus, a controlled swelling is appreciated for tissue 
engineering applications, indicating that the frozen SF/nanoHA composite hydrogels 
could be more adequate.  
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Degradability of a bone substitute is another important characteristic for whether the 
material will be accepted widely for tissue engineering applications. The ideal implant 
should degrade at a rate compatible with the rate of bone growth, physically creating 
open space for new bone tissue formation, until full regeneration is achieved. In vitro 
enzymatic hydrolysis provides a general idea of the biodegradability of a material. As a 
protein, SF is susceptible to biological degradation by proteolytic enzymes, such as 
protease [21]. The hydrogels incubated in phosphate buffer without the enzyme 
showed no significant degradation. On the contrary, materials incubated with protease 
were enzymatically degraded, which confirmed that the mass loss was due solely to 
enzymatic hydrolysis, showing the potential of SF as a biodegradable material. The 
final wastes of the enzymatic degradation of SF biomaterials are the corresponding 
amino acids, which are easily disposed in vivo. This is a crucial advantage of SF used in 
biomedical applications [21]. Furthermore, the degradation rate and the morphological 
structure changes were similar for the non-frozen and frozen hydrogels suggesting that 
pore size did not correlate with degradation rate. This has earlier been shown by Kim 
U. et al in SF scaffolds with different pore sizes exposed to a protease solution [22].  
Besides the aforementioned needful properties, which were successfully achieved, a 
strong argument to indicate a better performance with respect to bone regeneration, 
and that is being useful for predicting the in vivo bone bioactivity of a material, is the 
ability of the hydrogel to promote an apatite layer formation [23]. As for the apatite-
forming ability, SF/nanoHA hydrogels performed best with the highest amount of 
apatite being formed, and hence, increased osteoconductivity and tissue in-growth are 
expected after implantation. These results are in line with previous studies, showing 
that composite materials incorporating nanoHA improve apatite formation, which can 
be attributed to the dissolution of calcium and phosphate ions from nanoHA, and 
consequently this ceramic acts as nucleation agent at different sites for the growth of 
apatite crystals [18, 24].   
Considering the promising structural and physicochemical properties of frozen 
SF/nanoHA hydrogels developed in this work, these composites materials may provide 
a promising engineering solution to control the adhesion, proliferation and osteogenic 
differentiation of human bone marrow stromal cells (hBMSCs), which are critical cells 
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responsible for osteogenesis. For this reason, in vitro studies with hBMSCs were 
performed on both non-frozen and frozen SF and SF/nanoHA hydrogels. hBMSCs were 
able to adhere and proliferate on all materials, however cells in the hydrogels with 
nanoHA presented higher metabolic activity and proliferation rates, showing an 
inductive effect of the presence of nanoHA, consistent with previous studies that 
examined bone-related cell behavior on this ceramic [25-27]. For example, Xia Y et al 
reported that poly-ε-caprolactone (PCL) scaffolds incorporating nanoHA enabled 
better the attachment and proliferation of human bone marrow stromal cells in 
comparison with pure PCL scaffolds [27]. In the present work, this tendency was 
particularly achieved in the frozen composite hydrogels, which could be attributed to 
the well-constructed porous structure with larger pore sizes on frozen materials. An 
enhanced cell attachment and proliferation thorough SF/chitosan porous scaffolds 
with larger pores was also observed in a study conducted by Bhardwaj N et al [28]. 
Furthermore, a more prominent hBMSCs attachment, evidenced from more 
development of actin filaments, was observed in these frozen composite materials. 
Additionally, hBMSCs attached on SF/nanoHA hydrogels successfully expressed higher 
levels of ALP activity, an early osteoblastic differentiation marker widely used to 
evaluate the in vitro osteogenic differentiation [29]. Likewise, an ALP live cell stain 
assay showed that the cells were alive and functional, with better cell response in the 
SF/nanoHA hydrogels. The osteogenic induction of the composite materials containing 
nanoHA was found consistent with previous studies [30, 31]. The osteogenic potential 
of the SF/nanoHA hydrogels on the hBMSCs differentiation was also evidenced by the 
increased intensity of BMP-2 expression, which is a protein known to participate in the 
regulation of cell growth and differentiation, along with the induction of osteogenic 
progenitor cells in bone defects sites during the healing process [32]. Furthermore, 
BMP-2 has a critical role in inducing Runx-2 and Osterix expression to promote 
osteoblast differentiation [33, 34]. One interesting observation, in this work, was that 
ALP expression in hBMSCs was observed within the SF/nanoHA porous hydrogel, 
indicating not only cell infiltration into the material, and consequently migration, but 
also active production of ALP by the infiltrated cells. This cell migration at different 
levels in the 3D hydrogels constitute a main pillar of scaffold colonization ensuring 
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bone in-growth and bone tissue regeneration [35]. These biological findings are in line 
with the apatite-forming ability of the composite hydrogels, which proved that these 
materials provided a more bioactive substrate for cellular attachment, proliferation 
and differentiation.  
The possibility of promoting bone tissue growth while preventing bacterial adhesion 
and, consequently, implant-related infections, is undoubtedly highly desirable. 
Implant-associated infections are the result of microbial adhesion and subsequent 
biofilm formation at the implantation site protecting bacteria against host defenses 
and antibiotics. Additionally, an estimated 80% of bacterial infections in humans are 
caused by biofilms, and consequently the most pressing clinical impediments of the 
century [36, 37]. The uprising of antibiotic resistance a few years from its 
implementation has prompted the search for new fighting strategies. Metallic 
nanoparticles are a promising class of inorganic antimicrobial compounds, as they have 
broad spectrum of activity, and higher durability and stability promoting a long-term 
shelf-life, which is a key condition for the use of a biomaterial in clinical settings [38]. 
Furthermore, this experimental strategy may mitigate concerns about multi-drug 
resistant microorganisms commonly seen in approaches based on conventional 
antibiotics. Because of the well-known antimicrobial activity of silver [39] and gold [40] 
nanoparticles, the present SF/nanoHA hydrogel was modified with small amounts of in 
situ synthetized Ag or Au NPs. The resulting hydrogels endowed significant inhibition 
ability against major agents of biomaterial-associated infections in orthopedics, 
without hampering cell behavior. Hydrogels containing 0.5% of AgNPs presented 
strong antibacterial activity, both anti-sessile and anti-planktonic properties, reducing 
the bacteria attachment and further accumulation, and simultaneously allowed the 
adhesion and spreading of osteoblastic cells. The bacterial inhibition of hydrogels with 
AuNPs was not so high, as observed by others researchers [41], and may be due to the 
higher surface activity of the AgNPs as compared to the AuNPs [41]. However, the high 
degree of citocompatibility observed for the hydrogels with AuNPs toward osteoblast 
cells may be an interesting point to further studies, to evaluate if hydrogels modified 
with higher concentrations AuNPs could maintain the citocompatibility, and at same 
time improve the antimicrobial properties. Furthermore, it would be interesting to 
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assess if that higher concentrations of AuNPs could enhance the osteoblast 
proliferation and differentiation, since some studies with functionalized AuNPs have 
been reported to improve the bone tissue regeneration by promoting the proliferation 
of osteoblasts and osteogenic differentiation acting as osteogenic agents [42, 43].  
Gathering all the information of the current study, it is possible to conclude that frozen 
SF/nanoHA hydrogels presented excellent citocompatibility properties, since they 
provided an adequate environment for hBMSCs adhesion, proliferation and migration, 
and osteoblast differentiation. In addition, these composite hydrogels provided a 
convenient substrate for the inclusion of silver and gold nanoparticles, reducing the 
bacterial attachment and further accumulation, which could improve clinical outcomes 
related to biomaterial implant-associated infections.      
The results achieved in the present work suggested that SF/nanoHA hydrogels offer 
great potential to be considered as bone fillers for tissue engineering applications. To 
move a step forward in the characterization of this scaffold material, in vivo studies 
should be performed in order to validate the in vitro results, aiming at evaluating 
whether the newly developed composite hydrogels fulfil the requirements of 
biocompatibility and osteogenic potential. Secondly, the antimicrobial efficacy should 
be assessed using an animal model of bone infection. 
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Engineering composite hydrogels based on biodegradable polymers incorporating a 
bioactive ceramic represent a potentially interesting platform for the design of medical 
implants for successful bone regeneration. In this context, this work allowed to 
develop and optimize a composite hydrogel consisting of silk fibroin and nanoHA 
particles with enhanced physicochemical properties, which were ultimately favorable 
in the biological performance. The composite materials provided a more bioactive 
substrate for attachment, proliferation and osteogenic differentiation of human bone 
marrow stromal cells. Additionally, antimicrobial properties were provided to the 
composite material by in situ synthetizing of silver and gold nanoparticles. The 
bacterial inhibition of hydrogels with AuNPs was not so high when compared to 
materials with AgNPs. The SF/nanoHA hydrogels incorporating 0.5% of AgNPs were 
found to be a promising material as they presented strong antibacterial activity, 
reducing the bacterial attachment and further accumulation, while being 
cytocompatible with osteoblastic cells. This is particularly opportune considering the 
emergence of new resistant bacterial strains to the most potent antibiotics opening 
new avenues to prevent implant-related infections.  
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